BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078. [PMID: 19923578 DOI: 10.1056/nejmra0804647] [Cited by in Crossref: 1689] [Cited by in F6Publishing: 900] [Article Influence: 129.9] [Reference Citation Analysis]
Number Citing Articles
1 Direito R, Rocha J, Sepodes B, Eduardo-Figueira M. Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation. Pharmaceutics 2021;13:145. [PMID: 33499333 DOI: 10.3390/pharmaceutics13020145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Kim W, Jang JH, Zhong X, Seo H, Surh YJ. 15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis. Front Immunol 2021;12:615803. [PMID: 33633749 DOI: 10.3389/fimmu.2021.615803] [Reference Citation Analysis]
3 Zheng S, Hedl M, Abraham C. TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages. J Immunol 2015;194:1928-37. [PMID: 25567680 DOI: 10.4049/jimmunol.1401933] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
4 Spasova DS, Surh CD. Blowing on embers: commensal microbiota and our immune system. Front Immunol 2014;5:318. [PMID: 25120539 DOI: 10.3389/fimmu.2014.00318] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
5 Cho J, Kim S, Yang DH, Lee J, Park KW, Go J, Hyun CL, Jee Y, Kang KS. Mucosal Immunity Related to FOXP3+ Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease. J Korean Med Sci 2018;33:e336. [PMID: 30584414 DOI: 10.3346/jkms.2018.33.e336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Xiong T, Turner JE. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. Semin Immunopathol 2018;40:393-406. [PMID: 29568972 DOI: 10.1007/s00281-018-0670-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
7 Lo EM, Hotaling JM, Pastuszak AW. Urologic conditions associated with malignancy. Urol Oncol 2020;38:23-30. [PMID: 30611645 DOI: 10.1016/j.urolonc.2018.12.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Mouzaoui S, Djerdjouri B, Makhezer N, Kroviarski Y, El-Benna J, Dang PM. Tumor necrosis factor-α-induced colitis increases NADPH oxidase 1 expression, oxidative stress, and neutrophil recruitment in the colon: preventive effect of apocynin. Mediators Inflamm 2014;2014:312484. [PMID: 25276054 DOI: 10.1155/2014/312484] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
9 Ojode T, Schneider EH, Tiffany HL, Yung S, Gao JL, Murphy PM. The major leukocyte chemotactic and activating factors in the mouse gut lumen are not N-formylpeptide receptor 1 agonists. J Innate Immun 2013;5:2-14. [PMID: 22722599 DOI: 10.1159/000339572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Li H, Lai L, Shen J. Development of a susceptibility gene based novel predictive model for the diagnosis of ulcerative colitis using random forest and artificial neural network. Aging (Albany NY). 2020;12:20471-20482. [PMID: 33099536 DOI: 10.18632/aging.103861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hedl M, Abraham C. A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1. Proc Natl Acad Sci U S A 2014;111:13451-6. [PMID: 25197060 DOI: 10.1073/pnas.1404178111] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
12 Radulovic K, Niess JH. CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment? J Immunol Res 2015;2015:497056. [PMID: 25759842 DOI: 10.1155/2015/497056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
13 Dowdell AS, Cartwright IM, Goldberg MS, Kostelecky R, Ross T, Welch N, Glover LE, Colgan SP. The HIF target ATG9A is essential for epithelial barrier function and tight junction biogenesis.Mol Biol Cell. 2020;31:2249-2258. [PMID: 32726170 DOI: 10.1091/mbc.E20-05-0291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Sasidharan S, Yajnik V, Khalili H, Garber J, Xavier R, Ananthakrishnan AN. Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol 2017;52:570-6. [PMID: 28162010 DOI: 10.1080/00365521.2017.1286381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yan J, Hedl M, Abraham C. An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes. J Clin Invest 2017;127:2192-205. [PMID: 28436939 DOI: 10.1172/JCI86282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
16 Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C. Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation. Br J Pharmacol 2019;176:950-63. [PMID: 30714145 DOI: 10.1111/bph.14608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
17 Powell N, Pantazi E, Pavlidis P, Tsakmaki A, Li K, Yang F, Parker A, Pin C, Cozzetto D, Minns D, Stolarczyk E, Saveljeva S, Mohamed R, Lavender P, Afzali B, Digby-Bell J, Tjir-Li T, Kaser A, Friedman J, MacDonald TT, Bewick GA, Lord GM. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut 2020;69:578-90. [PMID: 31792136 DOI: 10.1136/gutjnl-2019-318483] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
18 Hedl M, Abraham C. A TPL2 (MAP3K8) disease-risk polymorphism increases TPL2 expression thereby leading to increased pattern recognition receptor-initiated caspase-1 and caspase-8 activation, signalling and cytokine secretion. Gut 2016;65:1799-811. [PMID: 26215868 DOI: 10.1136/gutjnl-2014-308922] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lee SM, Kim NH, Lee S, Kim YN, Heo JD, Rho JR, Jeong EJ. (10Z)-Debromohymenialdisine from Marine Sponge Stylissa sp. Regulates Intestinal Inflammatory Responses in Co-Culture Model of Epithelial Caco-2 Cells and THP-1 Macrophage Cells. Molecules 2019;24:E3394. [PMID: 31540496 DOI: 10.3390/molecules24183394] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Brunet E, Vela E, Melcarne L, Clèries M, Pontes C, Llovet LP, García-Iglesias P, Gallach M, Villòria A, Vergara M, Calvet X. Time Trends of Crohn's Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery. J Clin Med 2020;9:E2896. [PMID: 32911630 DOI: 10.3390/jcm9092896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Weizman T, Levin I, Zaretsky M, Sagi I, Aharoni A. Increased Potency of a Bi-specific TL1A-ADAM17 (TACE) Inhibitor by Cell Surface Targeting. Front Mol Biosci 2017;4:61. [PMID: 28879185 DOI: 10.3389/fmolb.2017.00061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
22 Manresa MC, Taylor CT. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cell Mol Gastroenterol Hepatol 2017;3:303-15. [PMID: 28462372 DOI: 10.1016/j.jcmgh.2017.02.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
23 Du Y, Ding H, Vanarsa K, Soomro S, Baig S, Hicks J, Mohan C. Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability. Nutrients 2019;11:E1743. [PMID: 31362373 DOI: 10.3390/nu11081743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Varzari A, Deyneko IV, Tudor E, Turcan S. Polymorphisms of glutathione S-transferase and methylenetetrahydrofolate reductase genes in Moldavian patients with ulcerative colitis: Genotype-phenotype correlation. Meta Gene 2016;7:76-82. [PMID: 26862484 DOI: 10.1016/j.mgene.2015.12.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
25 Ho SS, Wall C, Gearry RB, Keenan J, Day AS. A Pilot Study Evaluating Novel Urinary Biomarkers for Crohn's Disease. Inflamm Intest Dis 2020;5:212-20. [PMID: 33313074 DOI: 10.1159/000510682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 de Bruyn M, Breynaert C, Arijs I, De Hertogh G, Geboes K, Thijs G, Matteoli G, Hu J, Van Damme J, Arnold B, Ferrante M, Vermeire S, Van Assche G, Opdenakker G. Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease. Nat Commun 2017;8:15384. [PMID: 28561062 DOI: 10.1038/ncomms15384] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
27 Gorlé N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Front Immunol 2020;11:584165. [PMID: 33633723 DOI: 10.3389/fimmu.2020.584165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, Xu F, Cong Y, Xu X, Liu Z. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn’s disease. Clin Exp Immunol. 2013;173:102-111. [PMID: 23607532 DOI: 10.1111/cei.12084] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
29 Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep 2020;10:19273. [PMID: 33159156 DOI: 10.1038/s41598-020-76361-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Walsh E, Chah YW, Chin SM, Lochhead P, Yajnik V, Denmark V, Garber JJ, Khalili H. Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis. Inflamm Bowel Dis 2017;23:2035-41. [PMID: 28922252 DOI: 10.1097/MIB.0000000000001214] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu Z, Lee J, Krummey S, Lu W, Cai H, Lenardo MJ. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol. 2011;12:1063-1070. [PMID: 21983832 DOI: 10.1038/ni.2113] [Cited by in Crossref: 235] [Cited by in F6Publishing: 236] [Article Influence: 21.4] [Reference Citation Analysis]
32 Greish K, Taha S, Jasim A, Elghany SA, Sultan A, AlKhateeb A, Othman M, Jun F, Taurin S, Bakhiet M. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease. Clin Transl Med 2017;6:28. [PMID: 28770521 DOI: 10.1186/s40169-017-0157-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bonaz B. Is-there a place for vagus nerve stimulation in inflammatory bowel diseases? Bioelectron Med 2018;4:4. [PMID: 32232080 DOI: 10.1186/s42234-018-0004-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
34 Tian Y, Wang Y, Li F, Yang J, Xu Y, Ouyang M. LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis. Hum Cell 2021;34:37-48. [PMID: 33047284 DOI: 10.1007/s13577-020-00428-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ibuki M, Fukui K, Kanatani H, Mine Y. Anti-inflammatory effects of mannanase-hydrolyzed copra meal in a porcine model of colitis. J Vet Med Sci 2014;76:645-51. [PMID: 24430661 DOI: 10.1292/jvms.13-0424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
36 Wu H, Sun L, Lin DP, Shao XX, Xia SL, Lv M. Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast China. Gastroenterol Res Pract 2017;2017:4148651. [PMID: 28167958 DOI: 10.1155/2017/4148651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
37 Moein S, Vaghari-Tabari M, Qujeq D, Kashifard M, Shokri-Shirvani J, Hajian-Tilaki K. Association between serum folate with inflammatory markers, disease clinical activity and serum homocysteine in patients with inflammatory bowel disease. Does folate level have an effect on maintaining clinical remission? Acta Biomed 2020;91:e2020106. [PMID: 33525287 DOI: 10.23750/abm.v91i4.8467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ribaldone DG, Brigo S, Mangia M, Saracco GM, Astegiano M, Pellicano R. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines (Basel) 2020;7:E33. [PMID: 32560118 DOI: 10.3390/medicines7060033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dunsmore G, Koleva P, Ghobakhloo N, Sutton R, Ambrosio L, Meng X, Hotte N, Nguyen V, Madsen KL, Dieleman LA, Huang V, Elahi S. Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy. J Crohns Colitis 2019;13:230-44. [PMID: 30272151 DOI: 10.1093/ecco-jcc/jjy147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
40 Díaz-Jiménez D, Núñez LE, Beltrán CJ, Candia E, Suazo C, Álvarez-Lobos M, González MJ, Hermoso MA, Quera R. Soluble ST2: A new and promising activity marker in ulcerative colitis. World J Gastroenterol 2011; 17(17): 2181-2190 [PMID: 21633527 DOI: 10.3748/wjg.v17.i17.2181] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
41 Ye P, Xi Y, Huang Z, Xu P. Linking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights. Cancers (Basel) 2020;12:E1408. [PMID: 32486076 DOI: 10.3390/cancers12061408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
42 Xerfan EMS, Andersen ML, Tomimori J, Tufik S, Facina AS. Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues. Inflamm Bowel Dis 2021:izab208. [PMID: 34448840 DOI: 10.1093/ibd/izab208] [Reference Citation Analysis]
43 Peng LL, Wang Y, Zhu FL, Xu WD, Ji XL, Ni J. IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysis. Oncotarget 2017;8:4849-63. [PMID: 27902482 DOI: 10.18632/oncotarget.13607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
44 Biswas A, Kobayashi KS. Regulation of intestinal microbiota by the NLR protein family. Int Immunol 2013;25:207-14. [PMID: 23325116 DOI: 10.1093/intimm/dxs116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jin X, Chen D, Zheng RH, Zhang H, Chen YP, Xiang Z. miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism. World J Gastroenterol 2017; 23(1): 76-86 [PMID: 28104982 DOI: 10.3748/wjg.v23.i1.76] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
46 Rapalli A, Bertoni S, Arcaro V, Saccani F, Grandi A, Vivo V, Cantoni AM, Barocelli E. Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis. Front Pharmacol 2016;7:68. [PMID: 27047383 DOI: 10.3389/fphar.2016.00068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
47 Dulai PS, Singh S, Casteele NV, Boland BS, Sandborn WJ. How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:998-1009. [PMID: 26835982 DOI: 10.1097/MIB.0000000000000661] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
48 Cozier YC, Ruiz-Narvaez EA, McKinnon CJ, Berman JS, Rosenberg L, Palmer JR. Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis. Genes Immun 2012;13:573-8. [PMID: 22972473 DOI: 10.1038/gene.2012.42] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Minar P, Saeed SA, Afreen M, Kim MO, Denson LA. Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2016;62:715-22. [PMID: 26551317 DOI: 10.1097/MPG.0000000000001029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
50 Brunet E, Vela E, Melcarne L, Llovet LP, Puy A, Clèries M, Pontes C, García-Iglesias P, Villòria A, Kaplan GG, Calvet X. Heterogeneity in pharmacological treatment and outcomes in Crohn's disease patients in Catalonia: a population-based observational study. Ann Med 2022;54:1255-64. [PMID: 35499519 DOI: 10.1080/07853890.2022.2069851] [Reference Citation Analysis]
51 Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases. J Immunol Res 2020;2020:4873648. [PMID: 33015197 DOI: 10.1155/2020/4873648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Baier J, Gänsbauer M, Giessler C, Arnold H, Muske M, Schleicher U, Lukassen S, Ekici A, Rauh M, Daniel C, Hartmann A, Schmid B, Tripal P, Dettmer K, Oefner PJ, Atreya R, Wirtz S, Bogdan C, Mattner J. Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest 2020;130:5703-20. [PMID: 32721946 DOI: 10.1172/JCI126923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
53 Syed S, Michalski ES, Tangpricha V, Chesdachai S, Kumar A, Prince J, Ziegler TR, Suchdev PS, Kugathasan S. Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1650-8. [PMID: 28700535 DOI: 10.1097/MIB.0000000000001178] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
54 Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2016;22:2191-9. [PMID: 27482977 DOI: 10.1097/MIB.0000000000000852] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
55 Ihara S, Hirata Y, Koike K. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol 2017;52:777-87. [PMID: 28534191 DOI: 10.1007/s00535-017-1350-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
56 Wei ZZ, Li N. Application of confocal laser endomicroscopy in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(12): 1924-1929 [DOI: 10.11569/wcjd.v23.i12.1924] [Reference Citation Analysis]
57 Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ; New York Crohn's Disease Working Group. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet 2011;12:63. [PMID: 21548950 DOI: 10.1186/1471-2350-12-63] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
58 Laudisi F, Stolfi C, Monteleone G. Impact of Food Additives on Gut Homeostasis. Nutrients 2019;11:E2334. [PMID: 31581570 DOI: 10.3390/nu11102334] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 8.7] [Reference Citation Analysis]
59 Qazi T, Amaratunga T, Barnes EL, Fischer M, Kassam Z, Allegretti JR. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Microbes. 2017;8:574-588. [PMID: 28723262 DOI: 10.1080/19490976.2017.1353848] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
60 Vijayan V, Mueller S, Baumgart-Vogt E, Immenschuh S. Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol 2010; 16(25): 3112-3119 [PMID: 20593496 DOI: 10.3748/wjg.v16.i25.3112] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
61 Jiang J, Click B, Anderson AM, Koutroubakis IE, Rivers CR, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A, Regueiro M, Chang CC, Binion DG. Group-Based Trajectory Modeling of Healthcare Financial Charges in Inflammatory Bowel Disease: A Comprehensive Phenotype. Clin Transl Gastroenterol 2016;7:e181. [PMID: 27415619 DOI: 10.1038/ctg.2016.39] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
62 Loganes C, Lega S, Bramuzzo M, Vecchi Brumatti L, Piscianz E, Valencic E, Tommasini A, Marcuzzi A. Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. Nutrients 2017;9:E578. [PMID: 28587282 DOI: 10.3390/nu9060578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
63 Ambrose T, Simmons A. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? J Crohns Colitis 2019;13:525-35. [PMID: 30418525 DOI: 10.1093/ecco-jcc/jjy185] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
64 Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
65 Britt-Marie B, Sara P, Suzanne F, Frank RF, Anna RM. Temporal and Geographical Variation of Intestinal Ulcers in Grey Seals (Halichoerus grypus) and Environmental Contaminants in Baltic Biota during Four Decades. Animals (Basel) 2021;11:2968. [PMID: 34679987 DOI: 10.3390/ani11102968] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Moser AM, Spindelboeck W, Strohmaier H, Enzinger C, Gattringer T, Fuchs S, Fazekas F, Gorkiewicz G, Wurm P, Högenauer C, Khalil M. Mucosal biopsy shows immunologic changes of the colon in patients with early MS. Neurol Neuroimmunol Neuroinflamm 2017;4:e362. [PMID: 28638851 DOI: 10.1212/NXI.0000000000000362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 Pinton P. Computational models in inflammatory bowel disease. Clin Transl Sci 2022. [PMID: 35122401 DOI: 10.1111/cts.13228] [Reference Citation Analysis]
68 Wang K, Xu R, Snider AJ, Schrandt J, Li Y, Bialkowska AB, Li M, Zhou J, Hannun YA, Obeid LM, Yang VW, Mao C. Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system. Cell Death Dis 2016;7:e2124. [PMID: 26938296 DOI: 10.1038/cddis.2016.36] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
69 Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res. 2015;2015:489821. [PMID: 26090491 DOI: 10.1155/2015/489821] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 15.3] [Reference Citation Analysis]
70 Laudisi F, Di Fusco D, Dinallo V, Stolfi C, Di Grazia A, Marafini I, Colantoni A, Ortenzi A, Alteri C, Guerrieri F, Mavilio M, Ceccherini-Silberstein F, Federici M, MacDonald TT, Monteleone I, Monteleone G. The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress-Driven Mucus Depletion and Exacerbates Intestinal Inflammation. Cell Mol Gastroenterol Hepatol 2019;7:457-73. [PMID: 30765332 DOI: 10.1016/j.jcmgh.2018.09.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
71 Kurashima Y, Amiya T, Nochi T, Fujisawa K, Haraguchi T, Iba H, Tsutsui H, Sato S, Nakajima S, Iijima H, Kubo M, Kunisawa J, Kiyono H. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 2012;3:1034. [PMID: 22948816 DOI: 10.1038/ncomms2023] [Cited by in Crossref: 174] [Cited by in F6Publishing: 165] [Article Influence: 19.3] [Reference Citation Analysis]
72 Büchel F, Mittag F, Wrzodek C, Zell A, Gasser T, Sharma M. Integrative pathway-based approach for genome-wide association studies: identification of new pathways for rheumatoid arthritis and type 1 diabetes. PLoS One 2013;8:e78577. [PMID: 24205270 DOI: 10.1371/journal.pone.0078577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
73 Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn’s disease: NOD2, autophagy and ER stress converge. Gut. 2011;60:1580-1588. [PMID: 21252204 DOI: 10.1136/gut.2009.206466] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 12.1] [Reference Citation Analysis]
74 Reddavide R, Rotolo O, Caruso MG, Stasi E, Notarnicola M, Miraglia C, Nouvenne A, Meschi T, De' Angelis GL, Di Mario F, Leandro G. The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. Acta Biomed 2018;89:60-75. [PMID: 30561397 DOI: 10.23750/abm.v89i9-S.7952] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
75 Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL, Mobley M, Ge Z. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci USA. 2012;109:E1820-E1829. [PMID: 22689960 DOI: 10.1073/pnas.1207829109] [Cited by in Crossref: 161] [Cited by in F6Publishing: 153] [Article Influence: 16.1] [Reference Citation Analysis]
76 Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Törkvist L, Schmidt PT, Karling P, Ohlsson B. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011;60:1671-1677. [PMID: 21636646 DOI: 10.1136/gut.2011.241877] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
77 Macaluso FS, Maida M, Grova M, Crispino F, Teresi G, Orlando A, Orlando A. Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience. Therap Adv Gastroenterol 2021;14:17562848211010668. [PMID: 33995582 DOI: 10.1177/17562848211010668] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA. Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis 2014;20:1037-48. [PMID: 24788216 DOI: 10.1097/MIB.0000000000000049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
79 Akimova T, Xiao H, Liu Y, Bhatti TR, Jiao J, Eruslanov E, Singhal S, Wang L, Han R, Zacharia K, Hancock WW, Beier UH. Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells. Mucosal Immunol. 2014;7:1209-1220. [PMID: 24549276 DOI: 10.1038/mi.2014.10] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
80 Silva I, Pinto R, Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med 2019;8:E1574. [PMID: 31581545 DOI: 10.3390/jcm8101574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
81 Zwicky P, Unger S, Becher B. Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective. J Exp Med 2020;217:e20191123. [PMID: 31727781 DOI: 10.1084/jem.20191123] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
82 Blanco JR, Oteo JA. Gut microbiota: so much to explore! Expert Rev Anti Infect Ther 2013;11:759-61. [PMID: 23944197 DOI: 10.1586/14787210.2013.814837] [Reference Citation Analysis]
83 De la Fuente M, MacDonald TT, Hermoso MA. Editorial: Intestinal Homeostasis and Disease: A Complex Partnership Between Immune Cells, Non-Immune Cells, and the Microbiome. Front Immunol 2019;10:2775. [PMID: 31921105 DOI: 10.3389/fimmu.2019.02775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Towner RA, Smith N, Saunders D, Van Gordon SB, Tyler KR, Wisniewski AB, Greenwood-Van Meerveld B, Hurst RE. Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging. Neurogastroenterol Motil 2015;27:1571-9. [PMID: 26303228 DOI: 10.1111/nmo.12654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
85 Bilski J, Mazur-Bialy A, Wojcik D, Magierowski M, Surmiak M, Kwiecien S, Magierowska K, Hubalewska-Mazgaj M, Sliwowski Z, Brzozowski T. Effect of Forced Physical Activity on the Severity of Experimental Colitis in Normal Weight and Obese Mice. Involvement of Oxidative Stress and Proinflammatory Biomarkers. Nutrients. 2019;11:pii: E1127. [PMID: 31117199 DOI: 10.3390/nu11051127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
86 Kelly PM, Frosch EJ. Anxiety in Children with Chronic Medical Illness. In: Vasa RA, Roy AK, editors. Pediatric Anxiety Disorders. New York: Springer; 2013. pp. 317-43. [DOI: 10.1007/978-1-4614-6599-7_15] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Hong SJ, Katz S. The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management. Therap Adv Gastroenterol 2021;14:17562848211023399. [PMID: 34276809 DOI: 10.1177/17562848211023399] [Reference Citation Analysis]
88 Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2019;8:CD010233. [PMID: 31425621 DOI: 10.1002/14651858.CD010233.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
89 Ylisaukko-Oja T, Puttonen M, Jokelainen J, Koivusalo M, Tamminen K, Torvinen S, Voutilainen M. Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scand J Gastroenterol 2021;:1-9. [PMID: 34927504 DOI: 10.1080/00365521.2021.2014950] [Reference Citation Analysis]
90 Ferreira MR, Andreyev HJ. Editorial: Gut microbiota and chemotherapy- or radiation-induced gastrointestinal mucositis. Aliment Pharmacol Ther 2014;40:733-4. [PMID: 25123390 DOI: 10.1111/apt.12905] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
91 Kayahan H, Sari I, Cullu N, Yuksel F, Demir S, Akarsu M, Goktay Y, Unsal B, Akpinar H. Evaluation of early atherosclerosis in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57:2137-2143. [PMID: 22466100 DOI: 10.1007/s10620-012-2148-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
92 Vincent G, Novak EA, Siow VS, Cunningham KE, Griffith BD, Comerford TE, Mentrup HL, Stolz DB, Loughran P, Ranganathan S, Mollen KP. Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation. Antioxid Redox Signal 2020;33:1-19. [PMID: 32103677 DOI: 10.1089/ars.2018.7702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
93 Wu X, Lahiri A, Haines GK 3rd, Flavell RA, Abraham C. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury. J Immunol 2014;192:3409-18. [PMID: 24591373 DOI: 10.4049/jimmunol.1302436] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
94 Biswas A, Liu YJ, Hao L, Mizoguchi A, Salzman NH, Bevins CL, Kobayashi KS. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci USA. 2010;107:14739-14744. [PMID: 20679225 DOI: 10.1073/pnas.1003363107] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 10.2] [Reference Citation Analysis]
95 Carbonetto P, Stephens M. Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn’s disease. PLoS Genet. 2013;9:e1003770. [PMID: 24098138 DOI: 10.1371/journal.pgen.1003770] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
96 Corridoni D, Arseneau KO, Cominelli F. Inflammatory bowel disease. Immunol Lett. 2014;161:231-235. [PMID: 24938525 DOI: 10.1016/j.imlet.2014.04.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 9.8] [Reference Citation Analysis]
97 Xie D, Li F, Pang D, Zhao S, Zhang M, Ren Z, Geng C, Wang C, Wei N, Jiang P. Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis. J Inflamm Res 2021;14:2941-53. [PMID: 34239317 DOI: 10.2147/JIR.S313374] [Reference Citation Analysis]
98 Maida M, Morreale GC, Sferrazza S, Sinagra E, Scalisi G, Vitello A, Vettori G, Rossi F, Catarella D, Di Bartolo CE, Schillaci D, Raimondo D, Camilleri S, Orlando A, Macaluso FS. Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases. Dig Liver Dis 2021;53:1171-7. [PMID: 33994129 DOI: 10.1016/j.dld.2021.04.006] [Reference Citation Analysis]
99 Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2018;11:CD012774. [PMID: 30480772 DOI: 10.1002/14651858.CD012774.pub2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
100 Kim JW, Lee CK, Kim HJ, Shim JJ, Jang JY, Dong SH, Kim BH, Chang YW, Chi SG. Polymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean. Intest Res 2015;13:242-9. [PMID: 26130999 DOI: 10.5217/ir.2015.13.3.242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
101 Shores DR, Binion DG, Freeman BA, Baker PR. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2192-204. [PMID: 21910181 DOI: 10.1002/ibd.21560] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
102 Wendt E, Keshav S. CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease. Clin Exp Gastroenterol 2015;8:119-30. [PMID: 25897254 DOI: 10.2147/CEG.S48305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
103 Van Praet L, Jacques P, Van den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol 2012;8:288-95. [PMID: 22508429 DOI: 10.1038/nrrheum.2012.42] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
104 Ollech JE, Aharoni-Golan M, Weisshof R, Normatov I, Sapp AR, Kalakonda A, Israel A, Glick LR, Karrison T, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc 2019;90:269-75. [PMID: 30738034 DOI: 10.1016/j.gie.2019.01.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
105 Liu M, Lin X, Wang L, He Y, Chen M, Mao R. Thalidomide-induced sinus bradycardia in Crohn's disease: case report and literature review. J Int Med Res 2019;47:2228-33. [PMID: 30832535 DOI: 10.1177/0300060519833293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
106 Hubbard VM, Cadwell K. Viruses, autophagy genes, and Crohn's disease. Viruses 2011;3:1281-311. [PMID: 21994779 DOI: 10.3390/v3071281] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
107 Kwak MS, Kim KJ, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Elevated C-reactive protein is associated with disease progression in patients with mild Crohn's disease. Springerplus 2016;5:878. [PMID: 27386326 DOI: 10.1186/s40064-016-2606-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015;60:290-298. [PMID: 25204669 DOI: 10.1007/s10620-014-3350-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
109 Hedl M, Sun R, Abraham C. Disease Risk-Associated Genetic Variants in STAT1 and STAT4 Function in a Complementary Manner to Increase Pattern-Recognition Receptor-Induced Outcomes in Human Macrophages. J Immunol 2020;205:1406-18. [PMID: 32661180 DOI: 10.4049/jimmunol.1901112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, Leong RW. Epidemiology of inflammatory bowel disease in South America: A systematic review. World J Gastroenterol 2019; 25(47): 6866-6875 [PMID: 31885427 DOI: 10.3748/wjg.v25.i47.6866] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
111 Li L, Xu P, Zhang Z, Zhou X, Chen C, Lu C. Platelets can reflect the severity of Crohn's disease without the effect of anemia. Clinics (Sao Paulo) 2020;75:e1596. [PMID: 32667493 DOI: 10.6061/clinics/2020/e1596] [Reference Citation Analysis]
112 Boland BS, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Zou G, Chang JT. Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease. Inflamm Bowel Dis 2015;21:323-30. [PMID: 25545378 DOI: 10.1097/MIB.0000000000000264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
113 Wu XW, Wu L, Ji HZ, Wang FY. Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis. Dig Dis Sci. 2015;60:3203-3208. [PMID: 26031424 DOI: 10.1007/s10620-015-3733-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
114 Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2927-36. [PMID: 23867874 DOI: 10.1097/MIB.0b013e31829aad16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
115 Zhao J, Lu Q, Liu Y, Shi Z, Hu L, Zeng Z, Tu Y, Xiao Z, Xu Q. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies. J Immunol Res 2021;2021:8816041. [PMID: 33553436 DOI: 10.1155/2021/8816041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One. 2013;8:e56944. [PMID: 23457642 DOI: 10.1371/journal.pone.0056944eb] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Bharadwaj S, Narula N, Tandon P, Yaghoobi M. Role of endoscopy in inflammatory bowel disease. Gastroenterol Rep (Oxf) 2018;6:75-82. [PMID: 29780594 DOI: 10.1093/gastro/goy006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
118 Henry C, Bassignani A, Berland M, Langella O, Sokol H, Juste C. Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups. Cells 2022;11:1340. [DOI: 10.3390/cells11081340] [Reference Citation Analysis]
119 Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F. Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLoS One 2017;12:e0169102. [PMID: 28052094 DOI: 10.1371/journal.pone.0169102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
120 Sun YX, Wang X, Liao X, Guo J, Hou WB, Wang X, Liu JP, Liu ZL. An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis. BMC Complement Med Ther 2021;21:228. [PMID: 34517855 DOI: 10.1186/s12906-021-03387-y] [Reference Citation Analysis]
121 Hendrikx T, Watzenböck ML, Walenbergh SM, Amir S, Gruber S, Kozma MO, Grabsch HI, Koek GH, Pierik MJ, Staufer K, Trauner M, Kalhan SC, Jonkers D, Hofker MH, Binder CJ, Shiri-Sverdlov R. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease. BMC Med 2016;14:107. [PMID: 27443391 DOI: 10.1186/s12916-016-0652-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
122 Knieling F, Waldner MJ. Light and sound - emerging imaging techniques for inflammatory bowel disease. World J Gastroenterol 2016; 22(25): 5642-5654 [PMID: 27433080 DOI: 10.3748/wjg.v22.i25.5642] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
123 Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med 2019;216:482-500. [PMID: 30755454 DOI: 10.1084/jem.20182031] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
124 De Arcangelis A, Hamade H, Alpy F, Normand S, Bruyère E, Lefebvre O, Méchine-Neuville A, Siebert S, Pfister V, Lepage P, Laquerriere P, Dembele D, Delanoye-Crespin A, Rodius S, Robine S, Kedinger M, Van Seuningen I, Simon-Assmann P, Chamaillard M, Labouesse M, Georges-Labouesse E. Hemidesmosome integrity protects the colon against colitis and colorectal cancer. Gut 2017;66:1748-60. [PMID: 27371534 DOI: 10.1136/gutjnl-2015-310847] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
125 Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M. Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population. PLoS One 2018;13:e0195778. [PMID: 29649328 DOI: 10.1371/journal.pone.0195778] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
126 O'Neill RE, Du W, Mohammadpour H, Alqassim E, Qiu J, Chen G, McCarthy PL, Lee KP, Cao X. T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses. J Immunol 2017;199:3700-10. [PMID: 29046346 DOI: 10.4049/jimmunol.1700380] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
127 Laffin M, Fedorak R, Zalasky A, Park H, Gill A, Agrawal A, Keshteli A, Hotte N, Madsen KL. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019;9:12294. [PMID: 31444382 DOI: 10.1038/s41598-019-48749-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
128 Mizoguchi A, Takeuchi T, Himuro H, Okada T, Mizoguchi E. Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol. 2016;238:205-219. [PMID: 26387641 DOI: 10.1002/path.4640] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
129 Mezzasalma V, Manfrini E, Ferri E, Sandionigi A, La Ferla B, Schiano I, Michelotti A, Nobile V, Labra M, Di Gennaro P. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Res Int 2016;2016:4740907. [PMID: 27595104 DOI: 10.1155/2016/4740907] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
130 Liu GX, Gan HT. Effect of enteric nervous system on intestinal epithelial barrier in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2017; 25(2): 107-113 [DOI: 10.11569/wcjd.v25.i2.107] [Reference Citation Analysis]
131 Kwong EK, Zhou H. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Res 2019;3:19-24. [PMID: 31360579 DOI: 10.1016/j.livres.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
132 Dave M, Papadakis KA, Faubion WA. Immunology of inflammatory bowel disease and molecular targets for biologics. Gastroenterol Clin North Am. 2014;43:405-424. [PMID: 25110250 DOI: 10.1016/j.gtc.2014.05.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
133 van Haaften WT, Blokzijl T, Hofker HS, Olinga P, Dijkstra G, Bank RA, Boersema M. Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets. Therap Adv Gastroenterol 2020;13:1756284820952578. [PMID: 32922514 DOI: 10.1177/1756284820952578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Kenny EE, Pe’er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT. A genome-wide scan of Ashkenazi Jewish Crohn’s disease suggests novel susceptibility loci. PLoS Genet. 2012;8:e1002559. [PMID: 22412388 DOI: 10.1371/journal.pgen.1002559] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 11.0] [Reference Citation Analysis]
135 Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 2018;67:108-19. [PMID: 27802154 DOI: 10.1136/gutjnl-2016-312135] [Cited by in Crossref: 289] [Cited by in F6Publishing: 282] [Article Influence: 48.2] [Reference Citation Analysis]
136 Ashour RH, Hazem NM, AbdElfattah AA, El-Kady RA, Elmasry A. Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression. Int Immunopharmacol 2022;106:108620. [PMID: 35247859 DOI: 10.1016/j.intimp.2022.108620] [Reference Citation Analysis]
137 Lau KS, Cortez-Retamozo V, Philips SR, Pittet MJ, Lauffenburger DA, Haigis KM. Multi-scale in vivo systems analysis reveals the influence of immune cells on TNF-α-induced apoptosis in the intestinal epithelium. PLoS Biol 2012;10:e1001393. [PMID: 23055830 DOI: 10.1371/journal.pbio.1001393] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
138 Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol 2012;154:72-7. [PMID: 22464367 DOI: 10.1016/j.ajo.2012.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
139 Yang S, Liang X, Song J, Li C, Liu A, Luo Y, Ma H, Tan Y, Zhang X. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther 2021;12:315. [PMID: 34051868 DOI: 10.1186/s13287-021-02404-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Chebib N, Piégay F, Traclet J, Mion F, Mornex JF. Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease. Case Rep Pulmonol 2014;2014:368780. [PMID: 24653848 DOI: 10.1155/2014/368780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
141 Lahiri A, Hedl M, Abraham C. MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation. Proc Natl Acad Sci U S A 2015;112:10461-6. [PMID: 26240347 DOI: 10.1073/pnas.1501752112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
142 Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA. Mycobiota in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 2015;12:77-87. [PMID: 25385227 DOI: 10.1038/nrgastro.2014.188] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 12.1] [Reference Citation Analysis]
143 Wei J, Wei C, Wang M, Qiu X, Li Y, Yuan Y, Jin C, Leng L, Wang J, Yang X, He F. The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling. Proc Natl Acad Sci U S A 2014;111:8883-8. [PMID: 24879442 DOI: 10.1073/pnas.1309218111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
144 Lu Q, Yang M, Liang Y, Xu J, Xu H, Nie Y, Wang L, Yao J, Li D. Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. JIR 2022;Volume 15:1825-44. [DOI: 10.2147/jir.s353038] [Reference Citation Analysis]
145 Catalan-Serra I, Brenna Ø. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother 2018;14:2597-611. [PMID: 29624476 DOI: 10.1080/21645515.2018.1461297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
146 Sahoo D, Swanson L, Sayed IM, Katkar GD, Ibeawuchi SR, Mittal Y, Pranadinata RF, Tindle C, Fuller M, Stec DL, Chang JT, Sandborn WJ, Das S, Ghosh P. Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease. Nat Commun 2021;12:4246. [PMID: 34253728 DOI: 10.1038/s41467-021-24470-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Lu C, Yang J, Yu W, Li D, Xiang Z, Lin Y, Yu C. Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. PLoS One 2015;10:e0132036. [PMID: 26172950 DOI: 10.1371/journal.pone.0132036] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
148 Jiang YY, Li J, Li Y, Wang Q, Liu S, Fang K, Qian JM, Jin HZ. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum. Chin Med J (Engl) 2017;130:2674-9. [PMID: 29133754 DOI: 10.4103/0366-6999.218004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014;158:1000-10. [PMID: 25171403 DOI: 10.1016/j.cell.2014.08.006] [Cited by in Crossref: 625] [Cited by in F6Publishing: 589] [Article Influence: 89.3] [Reference Citation Analysis]
150 Martin Mena A, Langlois A, Speca S, Schneider L, Desreumaux P, Dubuquoy L, Bertin B. The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis. Front Immunol 2017;8:1052. [PMID: 28928735 DOI: 10.3389/fimmu.2017.01052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
151 Gao Y, Uffenheimer M, Ashamallah M, Grimaldi G, Swaminath A, Sultan K. Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review. Intest Res 2020;18:289-96. [PMID: 31671928 DOI: 10.5217/ir.2019.00073] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Ogata H, Watanabe M, Matsui T, Hase H, Okayasu M, Tsuchiya T, Shinmura Y, Hibi T. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease. J Crohns Colitis 2016;10:1033-41. [PMID: 26961546 DOI: 10.1093/ecco-jcc/jjw060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
153 Anderson A, Ferris LK, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Dunn M, Barrie A, Schwartz M, Regueiro M, Binion DG. Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients. Dig Dis Sci. 2018;63:2729-2739. [PMID: 29713987 DOI: 10.1007/s10620-018-5056-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
154 Bates J, Diehl L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol. 2014;232:112-120. [PMID: 24122796 DOI: 10.1002/path.4277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
155 Wei B, Pei G. microRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol 2010;7:175-81. [PMID: 20364159 DOI: 10.1038/cmi.2010.19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
156 Santhanam S, Alvarado DM, Ciorba MA. Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. Transl Res 2016;167:67-79. [PMID: 26297050 DOI: 10.1016/j.trsl.2015.07.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
157 Formiga RO, Alves Júnior EB, Vasconcelos RC, Guerra GCB, Antunes de Araújo A, Carvalho TG, Garcia VB, de Araújo Junior RF, Gadelha FAAF, Vieira GC, Sobral MV, Barbosa Filho JM, Spiller F, Batista LM. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. Int J Mol Sci 2020;21:E5870. [PMID: 32824269 DOI: 10.3390/ijms21165870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
158 Sharma D, Malik A, Steury MD, Lucas PC, Parameswaran N. Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation. Inflamm Bowel Dis 2015;21:2766-77. [PMID: 26296063 DOI: 10.1097/MIB.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
159 Li S, Takasu C, Lau H, Robles L, Vo K, Farzaneh T, Vaziri ND, Stamos MJ, Ichii H. Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways. Antioxidants (Basel) 2020;9:E354. [PMID: 32344663 DOI: 10.3390/antiox9040354] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
160 Murray K, Reardon C. The cholinergic anti-inflammatory pathway revisited. Neurogastroenterol Motil 2018;30. [PMID: 29468816 DOI: 10.1111/nmo.13288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
161 Gentschew L, Bishop KS, Han DY, Morgan AR, Fraser AG, Lam WJ, Karunasinghe N, Campbell B, Ferguson LR. Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand. Nutrients 2012;4:1247-59. [PMID: 23112913 DOI: 10.3390/nu4091247] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
162 Lischalk JW, Blacksburg S, Mendez C, Repka M, Sanchez A, Carpenter T, Witten M, Garbus JE, Evans A, Collins SP, Katz A, Haas J. Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease. Radiat Oncol 2021;16:126. [PMID: 34243797 DOI: 10.1186/s13014-021-01850-1] [Reference Citation Analysis]
163 Haberer LJ, McSherry I, Cargill A, McCarthy L. Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates. Eur J Clin Pharmacol 2014;70:37-45. [PMID: 24100471 DOI: 10.1007/s00228-013-1592-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
164 Qiao H, Fang D, Chen J, Sun Y, Kang C, Di L, Li J, Chen Z, Chen J, Gao Y. Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease. Drug Deliv 2017;24:233-42. [PMID: 28156160 DOI: 10.1080/10717544.2016.1245367] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
165 Abdel Hadi L, Di Vito C, Riboni L. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm 2016;2016:3827684. [PMID: 26880864 DOI: 10.1155/2016/3827684] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
166 Horowitz JE, Warner N, Staples J, Crowley E, Gosalia N, Murchie R, Van Hout C, Fiedler K, Welch G, King AK, Reid JG, Overton JD, Baras A, Shuldiner AR, Griffiths A, Gottesman O, Muise AM, Gonzaga-Jauregui C. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease. Sci Rep 2021;11:5595. [PMID: 33692434 DOI: 10.1038/s41598-021-84938-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Nielsen OH. New strategies for treatment of inflammatory bowel disease. Front Med (Lausanne). 2014;1:3. [PMID: 25685754 DOI: 10.3389/fmed.2014.00003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
168 De la Fuente M, Franchi L, Araya D, Díaz-Jiménez D, Olivares M, Álvarez-Lobos M, Golenbock D, González MJ, López-Kostner F, Quera R, Núñez G, Vidal R, Hermoso MA. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol 2014;304:384-92. [PMID: 24581881 DOI: 10.1016/j.ijmm.2014.01.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
169 Singh V, Gowda CP, Singh V, Ganapathy AS, Karamchandani DM, Eshelman MA, Yochum GS, Nighot P, Spiegelman VS. The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression. J Biol Chem 2020;295:8602-12. [PMID: 32385106 DOI: 10.1074/jbc.AC120.013646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
170 Hu LH, Fan YJ, Li Q, Guan JM, Qu B, Pei FH, Liu BR. Bortezomib protects against dextran sulfate sodium‑induced ulcerative colitis in mice. Mol Med Rep 2017;15:4093-9. [PMID: 28487944 DOI: 10.3892/mmr.2017.6524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
171 Jianzhong H. The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease. Clin Lab Med 2014;34:763-70. [PMID: 25439275 DOI: 10.1016/j.cll.2014.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
172 Kato M, Sugimoto K, Ikeya K, Takano R, Matsuura A, Miyazu T, Ishida N, Tamura S, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Hanai H. Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease. PLoS One 2021;16:e0254548. [PMID: 34242369 DOI: 10.1371/journal.pone.0254548] [Reference Citation Analysis]
173 Yu HC, Chen TP, Chang YC. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database. J Dent Sci 2018;13:242-7. [PMID: 30895127 DOI: 10.1016/j.jds.2018.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
174 Plenge R. GWASs and the age of human as the model organism for autoimmune genetic research. Genome Biol 2010;11:212. [PMID: 20441610 DOI: 10.1186/gb-2010-11-5-212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
175 van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol. 2010;6:559-566. [PMID: 20594129 DOI: 10.1586/eci.10.34] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
176 Liu B, Gulati AS, Cantillana V, Henry SC, Schmidt EA, Daniell X, Grossniklaus E, Schoenborn AA, Sartor RB, Taylor GA. Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2013;305:G573-84. [PMID: 23989005 DOI: 10.1152/ajpgi.00071.2013] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
177 Fayyad-Kazan H, Faour WH, Badran B, Lagneaux L, Najar M. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria. Inflamm Res. 2016;65:501-510. [PMID: 26956767 DOI: 10.1007/s00011-016-0933-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
178 Riffelmacher T, Giles DA, Zahner S, Dicker M, Andreyev AY, McArdle S, Perez-Jeldres T, van der Gracht E, Murray MP, Hartmann N, Tumanov AV, Kronenberg M. Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils. Mucosal Immunol 2021;14:679-90. [PMID: 33568785 DOI: 10.1038/s41385-021-00378-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 van Haaften WT, Mortensen JH, Karsdal MA, Bay-Jensen AC, Dijkstra G, Olinga P. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. Aliment Pharmacol Ther 2017;46:26-39. [PMID: 28481042 DOI: 10.1111/apt.14092] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
180 Holmer A, Singh S. Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases. Expert Rev Clin Immunol 2019;15:969-79. [PMID: 31322018 DOI: 10.1080/1744666X.2019.1646127] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
181 Nordzieke DE, Medraño-Fernandez I. The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling. Antioxidants (Basel) 2018;7:E168. [PMID: 30463362 DOI: 10.3390/antiox7110168] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
182 Muise AM, Walters T, Xu W, Shen-Tu G, Guo CH, Fattouh R, Lam GY, Wolters VM, Bennitz J, van Limbergen J, Renbaum P, Kasirer Y, Ngan BY, Turner D, Denson LA, Sherman PM, Duerr RH, Cho J, Lees CW, Satsangi J, Wilson DC, Paterson AD, Griffiths AM, Glogauer M, Silverberg MS, Brumell JH. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology 2011;141:633-41. [PMID: 21684284 DOI: 10.1053/j.gastro.2011.04.057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
183 Barrett CW, Reddy VK, Short SP, Motley AK, Lintel MK, Bradley AM, Freeman T, Vallance J, Ning W, Parang B, Poindexter SV, Fingleton B, Chen X, Washington MK, Wilson KT, Shroyer NF, Hill KE, Burk RF, Williams CS. Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage. J Clin Invest 2015;125:2646-60. [PMID: 26053663 DOI: 10.1172/JCI76099] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
184 McAlpine W, Wang KW, Choi JH, San Miguel M, McAlpine SG, Russell J, Ludwig S, Li X, Tang M, Zhan X, Choi M, Wang T, Bu CH, Murray AR, Moresco EMY, Turer EE, Beutler B. The class I myosin MYO1D binds to lipid and protects against colitis. Dis Model Mech 2018;11:dmm035923. [PMID: 30279225 DOI: 10.1242/dmm.035923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
185 Boada-Romero E, Serramito-Gómez I, Sacristán MP, Boone DL, Xavier RJ, Pimentel-Muiños FX. The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1. Nat Commun 2016;7:11821. [PMID: 27273576 DOI: 10.1038/ncomms11821] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
186 Jain R, Jain A, Jain S, Thakur SS, Jain SK. Linking bisphenol potential with deleterious effect on immune system: a review. Nucleus. [DOI: 10.1007/s13237-022-00383-6] [Reference Citation Analysis]
187 Leon G, Hernandez Santana YE, Irwin N, Giannoudaki E, O'Neill S, Csizmadia I, Gogarty M, Lee TJ, Ruane D, Long A, Fallon PG, Hussey S, Walsh PT. IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells. Mucosal Immunol 2022. [PMID: 35177818 DOI: 10.1038/s41385-022-00488-w] [Reference Citation Analysis]
188 Vaghari-Tabari M, Targhazeh N, Moein S, Qujeq D, Alemi F, Majidina M, Younesi S, Asemi Z, Yousefi B. From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs? Cancer Cell Int 2022;22:146. [PMID: 35410210 DOI: 10.1186/s12935-022-02557-3] [Reference Citation Analysis]
189 Yang H, Li Y, Shen S, Gan D, Han C, Wu J, Wang Z. Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2019;2019:7870424. [PMID: 31976001 DOI: 10.1155/2019/7870424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
190 Dmochowska N, Wardill HR, Hughes PA. Advances in Imaging Specific Mediators of Inflammatory Bowel Disease. Int J Mol Sci 2018;19:E2471. [PMID: 30134572 DOI: 10.3390/ijms19092471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
191 Yuan H, Zelkha S, Burkatovskaya M, Gupte R, Leeman SE, Amar S. Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci U S A 2013;110:E5059-68. [PMID: 24324141 DOI: 10.1073/pnas.1320862110] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
192 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
193 Shin SH, Song JL, Park MG, Park MH, Hwang SJ, Park KY. Effects of natural raw meal (NRM) on high-fat diet and dextran sulfate sodium (DSS)-induced ulcerative colitis in C57BL/6J mice. Nutr Res Pract 2015;9:619-27. [PMID: 26634051 DOI: 10.4162/nrp.2015.9.6.619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
194 Kamat N, Kedia S, Ghoshal UC, Nehra A, Makharia G, Sood A, Midha V, Gupta V, Choudhuri G, Ahuja V. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian J Gastroenterol. 2019;38:44-54. [PMID: 30645725 DOI: 10.1007/s12664-018-0922-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
195 Woo VL. Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature. Case Rep Dent 2015;2015:830472. [PMID: 26240765 DOI: 10.1155/2015/830472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
196 Sandborn WJ, Bhandari BR, Fogel R, Onken J, Yen E, Zhao X, Jiang Z, Ge D, Xin Y, Ye Z, French D, Silverman JA, Kanwar B, Subramanian GM, McHutchison JG, Lee SD, Shackelton LM, Pai RK, Levesque BG, Feagan BG. Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis. Aliment Pharmacol Ther 2016;44:157-69. [PMID: 27218676 DOI: 10.1111/apt.13653] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
197 Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ, Fu J, Deelen P, Groen HJ, Smolonska A, Weersma RK, Hofstra RM, Buurman WA, Rensen S, Wolfs MG, Platteel M, Zhernakova A, Elbers CC, Festen EM, Trynka G, Hofker MH, Saris CG, Ophoff RA, van den Berg LH, van Heel DA, Wijmenga C, Te Meerman GJ, Franke L. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011;7:e1002197. [PMID: 21829388 DOI: 10.1371/journal.pgen.1002197] [Cited by in Crossref: 255] [Cited by in F6Publishing: 237] [Article Influence: 23.2] [Reference Citation Analysis]
198 Wilson RG, Stevens BW, Guo AY, Russell CN, Thornton A, Cohen MA, Sturgeon HC, Giallourakis C, Khalili H, Nguyen DD, Yajnik V, Sauk J, Ananthakrishnan AN. High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2015;60:2136-43. [PMID: 25701321 DOI: 10.1007/s10620-015-3580-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
199 McCarville JL, Caminero A, Verdu EF. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016;9:580-593. [PMID: 27366225 DOI: 10.1177/1756283X16637819] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
200 Bruland T, Østvik AE, Sandvik AK, Hansen MD. Host-Viral Interactions in the Pathogenesis of Ulcerative Colitis. Int J Mol Sci 2021;22:10851. [PMID: 34639191 DOI: 10.3390/ijms221910851] [Reference Citation Analysis]
201 Gwiggner M, Martinez-Nunez RT, Whiteoak SR, Bondanese VP, Claridge A, Collins JE, Cummings JRF, Sanchez-Elsner T. MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1. Genes (Basel) 2018;9:E85. [PMID: 29438285 DOI: 10.3390/genes9020085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
202 Kanvinde S, Chhonker YS, Ahmad R, Yu F, Sleightholm R, Tang W, Jaramillo L, Chen Y, Sheinin Y, Li J, Murry DJ, Singh AB, Oupický D. Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease. Acta Biomater 2018;82:158-70. [PMID: 30342282 DOI: 10.1016/j.actbio.2018.10.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
203 Danese S, Grisham M, Hodge J, Telliez JB. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 2016;310:G155-G162. [PMID: 26608188 DOI: 10.1152/ajpgi.00311.2015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
204 Garcia-Carbonell R, Wong J, Kim JY, Close LA, Boland BS, Wong TL, Harris PA, Ho SB, Das S, Ernst PB, Sasik R, Sandborn WJ, Bertin J, Gough PJ, Chang JT, Kelliher M, Boone D, Guma M, Karin M. Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death. Proc Natl Acad Sci U S A 2018;115:E9192-200. [PMID: 30209212 DOI: 10.1073/pnas.1810584115] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
205 Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20(3): 814-821 [PMID: 24574754 DOI: 10.3748/wjg.v20.i3.814] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
206 Oka A, Ishimura N, Ishihara S. A New Dawn for the Use of Artificial Intelligence in Gastroenterology, Hepatology and Pancreatology. Diagnostics (Basel) 2021;11:1719. [PMID: 34574060 DOI: 10.3390/diagnostics11091719] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
207 Sun H, Lagarrigue F, Wang H, Fan Z, Lopez-Ramirez MA, Chang JT, Ginsberg MH. Distinct integrin activation pathways for effector and regulatory T cell trafficking and function. J Exp Med 2021;218:e20201524. [PMID: 33104169 DOI: 10.1084/jem.20201524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
208 Pazmandi J, Kalinichenko A, Ardy RC, Boztug K. Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunol Rev 2019;287:162-85. [PMID: 30565237 DOI: 10.1111/imr.12726] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
209 Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:1511. [PMID: 34829740 DOI: 10.3390/biomedicines9111511] [Reference Citation Analysis]
210 Seo DH, Che X, Kwak MS, Kim S, Kim JH, Ma HW, Kim DH, Kim TI, Kim WH, Kim SW, Cheon JH. Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease. Sci Rep. 2017;7:851. [PMID: 28404987 DOI: 10.1038/s41598-017-00840-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 10.4] [Reference Citation Analysis]
211 Hu H, Lei Y, Zhang W, Xiong P, Song L, Luo X, Jia B, Zhang F. Anti-inflammatory activity and safety of compound glycyrrhizin in ulcerative colitis: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods 2022;91:105004. [DOI: 10.1016/j.jff.2022.105004] [Reference Citation Analysis]
212 Maida M, Macaluso FS, Orlando A. Upper gastrointestinal tract involvement in Crohn's disease: A relevant yet underestimated problem. Dig Liver Dis 2021;53:1546-7. [PMID: 34593347 DOI: 10.1016/j.dld.2021.09.006] [Reference Citation Analysis]
213 Qv L, Mao S, Li Y, Zhang J, Li L. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:755650. [PMID: 34900751 DOI: 10.3389/fcimb.2021.755650] [Reference Citation Analysis]
214 Bai L, Scott MKD, Steinberg E, Kalesinskas L, Habtezion A, Shah NH, Khatri P. Computational drug repositioning of atorvastatin for ulcerative colitis. J Am Med Inform Assoc 2021;28:2325-35. [PMID: 34529084 DOI: 10.1093/jamia/ocab165] [Reference Citation Analysis]
215 Lee A, De Mei C, Fereira M, Marotta R, Yoon HY, Kim K, Kwon IC, Decuzzi P. Dexamethasone-loaded Polymeric Nanoconstructs for Monitoring and Treating Inflammatory Bowel Disease. Theranostics 2017;7:3653-66. [PMID: 29109767 DOI: 10.7150/thno.18183] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
216 Gupta R, Chaudhary AR, Shah BN, Jadhav AV, Zambad SP, Gupta RC, Deshpande S, Chauthaiwale V, Dutt C. Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis. Clin Exp Gastroenterol 2014;7:13-23. [PMID: 24493931 DOI: 10.2147/CEG.S51923] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
217 Strohl M, Gonczi L, Kurt Z, Bessissow T, L Lakatos P. Quality of care in inflammatory bowel diseases: What is the best way to better outcomes? World J Gastroenterol 2018; 24(22): 2363-2372 [PMID: 29904243 DOI: 10.3748/wjg.v24.i22.2363] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
218 Sun R, Hedl M, Abraham C. Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters. J Immunol 2019;202:3297-308. [PMID: 31028123 DOI: 10.4049/jimmunol.1800757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
219 Ogundepo S, Chiamaka AM, Olatinwo M, Adepoju D, Aladesanmi MT, Celestine UO, Ali KC, Umezinwa OJ, Olasore J, Alausa A. The role of diosgenin in crohn’s disease. Clin Phytosci 2022;8. [DOI: 10.1186/s40816-022-00338-z] [Reference Citation Analysis]
220 Korpe PS, Petri WA. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18:328-336. [PMID: 22633998 DOI: 10.1016/j.molmed.2012.04.007] [Cited by in Crossref: 266] [Cited by in F6Publishing: 241] [Article Influence: 26.6] [Reference Citation Analysis]
221 Lahad A, Weiss B. Current therapy of pediatric Crohn’s disease. World J Gastrointest Pathophysiol 2015; 6(2): 33-42 [PMID: 25977836 DOI: 10.4291/wjgp.v6.i2.33] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
222 Polese L, Boetto R, De Franchis G, Angriman I, Porzionato A, Norberto L, Sturniolo GC, Macchi V, De Caro R, Merigliano S. B1a lymphocytes in the rectal mucosa of ulcerative colitis patients. World J Gastroenterol 2012; 18(2): 144-149 [PMID: 22253520 DOI: 10.3748/wjg.v18.i2.144] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
223 Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, Andriantsitohaina R. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One 2013;8:e73088. [PMID: 24019899 DOI: 10.1371/journal.pone.0073088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
224 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(1): 112-125 [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
225 Kim YN, Ji YK, Kim NH, Van Tu N, Rho JR, Jeong EJ. Isoquinolinequinone Derivatives from a Marine Sponge (Haliclona sp.) Regulate Inflammation in In Vitro System of Intestine. Mar Drugs 2021;19:90. [PMID: 33557170 DOI: 10.3390/md19020090] [Reference Citation Analysis]
226 Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017;2:17023. [PMID: 29158945 DOI: 10.1038/sigtrans.2017.23] [Cited by in Crossref: 1706] [Cited by in F6Publishing: 1539] [Article Influence: 341.2] [Reference Citation Analysis]
227 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
228 Di Spirito F, Toti P, Pilone V, Carinci F, Lauritano D, Sbordone L. The Association between Periodontitis and Human Colorectal Cancer: Genetic and Pathogenic Linkage. Life (Basel) 2020;10:E211. [PMID: 32962181 DOI: 10.3390/life10090211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
229 Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology 2021:S0016-5085(21)03707-0. [PMID: 34757143 DOI: 10.1053/j.gastro.2021.10.035] [Reference Citation Analysis]
230 Bohr J, Wickbom A, Hegedus A, Nyhlin N, Hultgren Hörnquist E, Tysk C. Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol. 2014;7:273-284. [PMID: 25170275 DOI: 10.2147/ceg.s63905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
231 Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr 2021;9:e0073021. [PMID: 34612661 DOI: 10.1128/Spectrum.00730-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Zhang S, Langer R, Traverso G. Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease. Nano Today 2017;16:82-96. [PMID: 31186671 DOI: 10.1016/j.nantod.2017.08.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
233 Myklebust-Hansen T, Aamodt G, Haugen M, Brantsæter AL, Vatn MH, Bengtson MB. Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa). Inflamm Bowel Dis 2017;24:12-24. [PMID: 29272477 DOI: 10.1093/ibd/izx006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
234 Wang PQ, Hu J, Al Kazzi ES, Akhuemonkhan E, Zhi M, Gao X, de Paula Pessoa RH, Ghazaleh S, Cornelius T, Sabunwala SA, Ghadermarzi S, Tripathi K, Lazarev M, Hu PJ, Hutfless S. Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States. World J Gastrointest Pharmacol Ther 2016; 7(4): 556-563 [PMID: 27867689 DOI: 10.4292/wjgpt.v7.i4.556] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
235 Niess JH, Klaus J, Stephani J, Pflüger C, Degenkolb N, Spaniol U, Mayer B, Lahr G, von Boyen GB. NOD2 polymorphism predicts response to treatment in Crohn’s disease--first steps to a personalized therapy. Dig Dis Sci. 2012;57:879-886. [PMID: 22147245 DOI: 10.1007/s10620-011-1977-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
236 Takahara M, Takaki A, Hiraoka S, Takei K, Yasutomi E, Igawa S, Yamamoto S, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Udono H, Okada H. Metformin ameliorates chronic colitis in a mouse model by regulating interferon‐γ‐producing lamina propria CD4 + T cells through AMPK activation. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202100831rr] [Reference Citation Analysis]
237 Wenzel UA, Magnusson MK, Rydström A, Jonstrand C, Hengst J, Johansson ME, Velcich A, Öhman L, Strid H, Sjövall H. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis. PLoS One. 2014;9:e100217. [PMID: 24945909 DOI: 10.1371/journal.pone.0100217] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
238 Langhorst J, Frede A, Knott M, Pastille E, Buer J, Dobos GJ, Westendorf AM. Distinct Kinetics in the Frequency of Peripheral CD4+ T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal. PLoS One. 2014;9:e104257. [PMID: 25144293 DOI: 10.1371/journal.pone.0104257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
239 Choi JS, Kim KH, Lau LF. The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol. 2015;8:1285-1296. [PMID: 25807183 DOI: 10.1038/mi.2015.19] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
240 Kim HJ. Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of Atherosclerosis. Korean J Physiol Pharmacol 2015;19:479-84. [PMID: 26557013 DOI: 10.4196/kjpp.2015.19.6.479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
241 Kim S, Lee S, Lee H, Ju S, Park S, Kwon D, Yoo JW, Yoon IS, Min DS, Jung YS, Jung Y. A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats. Pharmaceutics 2020;12:E843. [PMID: 32899177 DOI: 10.3390/pharmaceutics12090843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Thakur PC, Davison JM, Stuckenholz C, Lu L, Bahary N. Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish. Dis Model Mech. 2014;7:93-106. [PMID: 24135483 DOI: 10.1242/dmm.012864] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
243 Wang P, Hu J, Ghadermarzi S, Raza A, O'Connell D, Xiao A, Ayyaz F, Zhi M, Zhang Y, Parekh NK, Lazarev M, Parian A, Brant SR, Bedine M, Truta B, Hu P, Banerjee R, Hutfless SM. Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA. Dig Dis Sci 2018;63:2703-13. [PMID: 29862485 DOI: 10.1007/s10620-018-5142-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
244 Zhang J, Lu Y, Wang Y, Ren X, Han J. The impact of the intestinal microbiome on bone health. Intractable Rare Dis Res 2018;7:148-55. [PMID: 30181933 DOI: 10.5582/irdr.2018.01055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
245 Mead BE, Hattori K, Levy L, Imada S, Goto N, Vukovic M, Sze D, Kummerlowe C, Matute JD, Duan J, Langer R, Blumberg RS, Ordovas-Montanes J, Yilmaz ÖH, Karp JM, Shalek AK. Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation. Nat Biomed Eng 2022. [PMID: 35314801 DOI: 10.1038/s41551-022-00863-9] [Reference Citation Analysis]
246 Runtsch MC, Hu R, Alexander M, Wallace J, Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X. MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget. 2015;6:28556-28572. [PMID: 26456940 DOI: 10.18632/oncotarget.5597] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
247 Iskandar HN, Ciorba MA. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res. 2012;159:313-325. [PMID: 22424434 DOI: 10.1016/j.trsl.2012.01.001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 11.6] [Reference Citation Analysis]
248 Matsumoto Y, Dimitriou ID, La Rose J, Lim M, Camilleri S, Law N, Adissu HA, Tong J, Moran MF, Chruscinski A, He F, Asano Y, Katsuyama T, Sada KE, Wada J, Rottapel R. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. J Clin Invest 2022;132:e140869. [PMID: 35362478 DOI: 10.1172/JCI140869] [Reference Citation Analysis]
249 Giudici F, Maggi L, Santi R, Cosmi L, Annunziato F, Nesi G, Barra G, Bassotti G, De Palma R, Tonelli F. Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy. 2015;13:12. [PMID: 26203298 DOI: 10.1186/s12948-015-0018-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
250 Bamias G, Pizarro TT, Cominelli F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res 2016;167:104-15. [PMID: 26408803 DOI: 10.1016/j.trsl.2015.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
251 Si C, Zhang R, Wu T, Lu G, Hu Y, Zhang H, Xu F, Wei P, Chen K, Tang H, Yeretssian G, Xiong H. Dendritic cell-derived nitric oxide inhibits the differentiation of effector dendritic cells. Oncotarget 2016;7:74834-45. [PMID: 27556858 DOI: 10.18632/oncotarget.11361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
252 Sun R, Abraham C. IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant. Cell Mol Gastroenterol Hepatol 2020;10:673-97. [PMID: 32474165 DOI: 10.1016/j.jcmgh.2020.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Kaser A, Blumberg RS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology. 2011;140:1738-1747. [PMID: 21530740 DOI: 10.1053/j.gastro.2011.02.048] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis]
254 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
255 Patel H, Lissoos T, Rubin DT. Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States. PLoS One 2017;12:e0175099. [PMID: 28426675 DOI: 10.1371/journal.pone.0175099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
256 Mosli MH, Parker CE, Nelson SA, Baker KA, MacDonald JK, Zou GY, Feagan BG, Khanna R, Levesque BG, Jairath V. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev 2017;5:CD011256. [PMID: 28542712 DOI: 10.1002/14651858.CD011256.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
257 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 42.3] [Reference Citation Analysis]
258 Kammeyer A, Peters CP, Meijer SL, Te Velde AA. Anti-inflammatory effects of urocanic Acid derivatives in models ex vivo and in vivo of inflammatory bowel disease. ISRN Inflamm 2012;2012:898153. [PMID: 24049652 DOI: 10.5402/2012/898153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
259 Dey YN, Sharma G, Wanjari MM, Kumar D, Lomash V, Jadhav AD. Beneficial effect of Amorphophallus paeoniifolius tuber on experimental ulcerative colitis in rats. Pharm Biol 2017;55:53-62. [PMID: 27600166 DOI: 10.1080/13880209.2016.1226904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
260 Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol. 2010;177:2804-2815. [PMID: 21037074 DOI: 10.2353/ajpath.2010.100378] [Cited by in Crossref: 105] [Cited by in F6Publishing: 106] [Article Influence: 8.8] [Reference Citation Analysis]
261 Semiz A, Ozgun Acar O, Cetin H, Semiz G, Sen A. Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis. J Transl Int Med 2020;8:177-87. [PMID: 33062594 DOI: 10.2478/jtim-2020-0027] [Reference Citation Analysis]
262 Zhang W, Hui KY, Gusev A, Warner N, Ng SM, Ferguson J, Choi M, Burberry A, Abraham C, Mayer L. Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3. Genes Immun. 2013;14:310-316. [PMID: 23615072 DOI: 10.1038/gene.2013.19] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
263 Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci. 2014;15:9594-9627. [PMID: 24886810 DOI: 10.3390/ijms15069594] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
264 Gupta S, Allegretti JR. Mimics of Crohn's Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.006] [Reference Citation Analysis]
265 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
266 Machtaler S, Knieling F, Luong R, Tian L, Willmann JK. Assessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular Imaging. Theranostics. 2015;5:1175-1186. [PMID: 26379784 DOI: 10.7150/thno.13048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
267 Ramjeet M, Hussey S, Philpott DJ, Travassos LH. 'Nodophagy': New crossroads in Crohn disease pathogenesis. Gut Microbes 2010;1:307-15. [PMID: 21327039 DOI: 10.4161/gmic.1.5.13295] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
268 Bourgonje AR, von Martels JZH, Gabriëls RY, Blokzijl T, Buist-Homan M, Heegsma J, Jansen BH, van Dullemen HM, Festen EAM, Ter Steege RWF, Visschedijk MC, Weersma RK, de Vos P, Faber KN, Dijkstra G. A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Front Med (Lausanne) 2019;6:251. [PMID: 31772929 DOI: 10.3389/fmed.2019.00251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
269 Yang FY, Chen R, Zhang X, Huang B, Tsang LL, Li X, Jiang X. Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation. Cell Transplant 2018;27:1352-67. [PMID: 30095002 DOI: 10.1177/0963689718780304] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
270 Laffin MR, Perry T, Park H, Gillevet P, Sikaroodi M, Kaplan GG, Fedorak RN, Kroeker K, Dieleman LA, Dicken B, Madsen KL. Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn's disease. Sci Rep 2018;8:9734. [PMID: 29950676 DOI: 10.1038/s41598-018-28071-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
271 Xiao B, Zhang Z, Viennois E, Kang Y, Zhang M, Han MK, Chen J, Merlin D. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation. Theranostics 2016;6:2250-66. [PMID: 27924161 DOI: 10.7150/thno.15710] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 13.7] [Reference Citation Analysis]
272 Montbarbon M, Pichavant M, Langlois A, Erdual E, Maggiotto F, Neut C, Mallevaey T, Dharancy S, Dubuquoy L, Trottein F, Cortot A, Desreumaux P, Gosset P, Bertin B. Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment. PLoS One 2013;8:e62208. [PMID: 23638007 DOI: 10.1371/journal.pone.0062208] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
273 Thurner L, Stöger E, Fadle N, Klemm P, Regitz E, Kemele M, Bette B, Held G, Dauer M, Lammert F, Preuss KD, Zimmer V, Pfreundschuh M. Proinflammatory progranulin antibodies in inflammatory bowel diseases. Dig Dis Sci 2014;59:1733-42. [PMID: 24591016 DOI: 10.1007/s10620-014-3089-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
274 Loke P, Lim YA. Helminths and the microbiota: parts of the hygiene hypothesis. Parasite Immunol 2015;37:314-23. [PMID: 25869420 DOI: 10.1111/pim.12193] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
275 Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012;142:482-9. [PMID: 22155183 DOI: 10.1053/j.gastro.2011.11.040] [Cited by in Crossref: 257] [Cited by in F6Publishing: 237] [Article Influence: 23.4] [Reference Citation Analysis]
276 Mączka W, Grabarczyk M, Wińska K. Can Antioxidants Reduce the Toxicity of Bisphenol? Antioxidants (Basel) 2022;11:413. [PMID: 35204295 DOI: 10.3390/antiox11020413] [Reference Citation Analysis]
277 Gorenjak M, Zupin M, Jezernik G, Skok P, Potočnik U. Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Sci Rep 2021;11:5449. [PMID: 33750834 DOI: 10.1038/s41598-021-84909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Heller MT, Hattoum A. Imaging of acute right lower quadrant abdominal pain: differential diagnoses beyond appendicitis. Emerg Radiol 2012;19:61-73. [PMID: 22072087 DOI: 10.1007/s10140-011-0997-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
279 Perez K, Ngollo M, Rabinowitz K, Hamoudi N, Seksik P, Xavier RJ, Daly MJ, Dotan I, Le Bourhis L, Allez M. Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases. Inflamm Bowel Dis 2021:izab311. [PMID: 34928348 DOI: 10.1093/ibd/izab311] [Reference Citation Analysis]
280 Weizman AV, Silverberg MS. Have genomic discoveries in inflammatory bowel disease translated into clinical progress? Curr Gastroenterol Rep. 2012;14:139-145. [PMID: 22302508 DOI: 10.1007/s11894-012-0248-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
281 She YY, Kong XB, Ge YP, Liu ZY, Chen JY, Jiang JW, Jiang HB, Fang SL. Periodontitis and inflammatory bowel disease: a meta-analysis. BMC Oral Health 2020;20:67. [PMID: 32164696 DOI: 10.1186/s12903-020-1053-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
282 Rendon JL, Choudhry MA. Th17 cells: critical mediators of host responses to burn injury and sepsis. J Leukoc Biol 2012;92:529-38. [PMID: 22753950 DOI: 10.1189/jlb.0212083] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
283 Wang J, Nakamura TI, Tuskey AG, Behm BW. Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study. Intest Res 2019;17:496-503. [PMID: 31602961 DOI: 10.5217/ir.2019.00050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
284 Swan ZD, Wonderlich ER, Barratt-Boyes SM. Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques. Eur J Immunol 2016;46:446-54. [PMID: 26549608 DOI: 10.1002/eji.201545738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
285 Ciccocioppo R, Vanoli A, Klersy C, Imbesi V, Boccaccio V, Manca R, Betti E, Cangemi GC, Strada E, Besio R, Rossi A, Falcone C, Ardizzone S, Fociani P, Danelli P, Corazza GR. Role of the advanced glycation end products receptor in Crohn’s disease inflammation. World J Gastroenterol 2013; 19(45): 8269-8281 [PMID: 24363518 DOI: 10.3748/wjg.v19.i45.8269] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
286 Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, Parian A, Matarese LE, Bracewell K, MacDonald JK, Gordon M, Mullin GE. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev 2019;2:CD012839. [PMID: 30736095 DOI: 10.1002/14651858.CD012839.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
287 Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E. Clinical importance of IL-22 cascade in IBD. J Gastroenterol 2018;53:465-74. [PMID: 29075900 DOI: 10.1007/s00535-017-1401-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 12.4] [Reference Citation Analysis]
288 Magen R, Shaoul R. Alternative & complementary treatment for pediatric inflammatory bowel disease. Transl Pediatr 2019;8:428-35. [PMID: 31993357 DOI: 10.21037/tp.2019.09.02] [Reference Citation Analysis]
289 Huang Z, Ma J, Chen M, Jiang H, Fu Y, Gan J, Dong L, Zhang J, Chen J. Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors. Mol Ther 2015;23:1611-21. [PMID: 26073885 DOI: 10.1038/mt.2015.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
290 Li LJ, Gong C, Zhao MH, Feng BS. Role of interleukin-22 in inflammatory bowel disease. World J Gastroenterol 2014; 20(48): 18177-18188 [PMID: 25561785 DOI: 10.3748/wjg.v20.i48.18177] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
291 Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW; IBD Sydney Organisation and the Asia-Pacific Crohn's and Colitis Epidemiology Study (ACCESS) Group. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res 2018;16:409-15. [PMID: 30090040 DOI: 10.5217/ir.2018.16.3.409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
292 Hori Y, Yamamoto H, Kawatoko S, Nozaki Y, Torisu T, Kato K, Koga Y, Miyoshi H, Ohshima K, Tateishi Y, Nakamura S, Kitazono T, Oda Y. Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: A clinicopathological study of 15 cases. Hum Pathol 2022:S0046-8177(21)00218-5. [PMID: 34990621 DOI: 10.1016/j.humpath.2021.12.010] [Reference Citation Analysis]
293 Auci DL, Egilmez NK, Dryden GW. Anti-Fibrotic Potential of All Trans Retinoic Acid in Inflammatory Bowel Disease. J Gastroenterol Pancreatol Liver Disord. 2018;6 . [PMID: 30740522 DOI: 10.15226/2374-815x/6/3/001126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Smith PD, Shimamura M, Musgrove LC, Dennis EA, Bimczok D, Novak L, Ballestas M, Fenton A, Dandekar S, Britt WJ, Smythies LE. Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses. J Immunol 2014;193:5604-12. [PMID: 25355920 DOI: 10.4049/jimmunol.1302608] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
295 Ranjan K. Intestinal Immune Homeostasis and Inflammatory Bowel Disease: A Perspective on Intracellular Response Mechanisms. GastrointestDisord 2020;2:246-66. [DOI: 10.3390/gidisord2030024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Luo Y, Wu X, Ma Z, Tan W, Wang L, Na D, Zhang G, Yin A, Huang H, Xia D, Zhang Y, Shi X, Wang L. Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice. Cell Mol Immunol 2016;13:688-99. [PMID: 27086950 DOI: 10.1038/cmi.2016.16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
297 Mukaida N, Sasakki S, Popivanova BK. Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer. Cancers (Basel) 2011;3:2811-26. [PMID: 24212934 DOI: 10.3390/cancers3032811] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
298 Biondi A, Zoccali M, Costa S, Troci A, Contessini-Avesani E, Fichera A. Surgical treatment of ulcerative colitis in the biologic therapy era. World J Gastroenterol 2012; 18(16): 1861-1870 [PMID: 22563165 DOI: 10.3748/wjg.v18.i16.1861] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
299 Wang L, Ray A, Jiang X, Wang JY, Basu S, Liu X, Qian T, He R, Dittel BN, Chu Y. T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis. Mucosal Immunol. 2015;8:1297-1312. [PMID: 25807185 DOI: 10.1038/mi.2015.20] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
300 Knod JL, Crawford K, Dusing M, Collins MH, Chernoguz A, Frischer JS. Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease. J Gastrointest Surg. 2016;20:624-630. [PMID: 26530519 DOI: 10.1007/s11605-015-3002-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
301 Sevrin G, Massier S, Chassaing B, Agus A, Delmas J, Denizot J, Billard E, Barnich N. Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability. Gut Microbes 2020;11:364-80. [PMID: 29494278 DOI: 10.1080/19490976.2017.1421886] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
302 Click B, Ramos Rivers C, Koutroubakis IE, Babichenko D, Anderson AM, Hashash JG, Dunn MA, Schwartz M, Swoger J, Baidoo L, Barrie A 3rd, Regueiro M, Binion DG. Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1442-1449. [PMID: 26950309 DOI: 10.1097/mib.0000000000000763] [Cited by in Crossref: 50] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
303 Raman R, Patel KJ, Ranjan K. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules 2021;11:993. [PMID: 34356617 DOI: 10.3390/biom11070993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Payne SC, Furness JB, Burns O, Sedo A, Hyakumura T, Shepherd RK, Fallon JB. Anti-inflammatory Effects of Abdominal Vagus Nerve Stimulation on Experimental Intestinal Inflammation. Front Neurosci 2019;13:418. [PMID: 31133776 DOI: 10.3389/fnins.2019.00418] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
305 Fernandes SA, Rossoni C, Koch VW, Imbrizi M, Evangelista-Poderoso R, Pinto LP, Magro DO. Phase angle through electrical bioimpedance as a predictor of cellularity in inflammatory bowel disease. Artif Intell Gastroenterol 2021; 2(4): 111-123 [DOI: 10.35712/aig.v2.i4.111] [Reference Citation Analysis]
306 Liu Q, Zuo R, Wang K, Nong FF, Fu YJ, Huang SW, Pan ZF, Zhang Y, Luo X, Deng XL, Zhang XX, Zhou L, Chen Y. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacol Sin 2020;41:771-81. [PMID: 31937929 DOI: 10.1038/s41401-019-0335-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
307 Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 2017; 23(33): 6016-6029 [PMID: 28970718 DOI: 10.3748/wjg.v23.i33.6016] [Cited by in CrossRef: 215] [Cited by in F6Publishing: 200] [Article Influence: 43.0] [Reference Citation Analysis]
308 Park JS, Choi J, Kwon JY, Jung KA, Yang CW, Park SH, Cho ML. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model. J Transl Med 2018;16:37. [PMID: 29466999 DOI: 10.1186/s12967-018-1410-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
309 Schey R, Dornhoff H, Baier JL, Purtak M, Opoka R, Koller AK, Atreya R, Rau TT, Daniel C, Amann K. CD101 inhibits the expansion of colitogenic T cells. Mucosal Immunol. 2016;9:1205-1217. [PMID: 26813346 DOI: 10.1038/mi.2015.139] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
310 Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012;3:107. [PMID: 22586430 DOI: 10.3389/fimmu.2012.00107] [Cited by in Crossref: 192] [Cited by in F6Publishing: 191] [Article Influence: 19.2] [Reference Citation Analysis]
311 Wang C, Li J. Pathogenic Microorganisms and Pancreatic Cancer. Gastrointest Tumors 2015;2:41-7. [PMID: 26673459 DOI: 10.1159/000380896] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
312 Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vich Vila A, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK. The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1. BMC Gastroenterol 2019;19:5. [PMID: 30621600 DOI: 10.1186/s12876-018-0917-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
313 Hammer L, Furtado S, Mathiowitz E, Auci DL. Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2020; 11(5): 79-92 [PMID: 33251033 DOI: 10.4292/wjgpt.v11.i5.79] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Khademi Z, Saneei P, Hassanzadeh-Keshteli A, Daghaghzadeh H, Tavakkoli H, Adibi P, Esmaillzadeh A. Association Between Inflammatory Potential of the Diet and Ulcerative Colitis: A Case-Control Study. Front Nutr 2020;7:602090. [PMID: 33681269 DOI: 10.3389/fnut.2020.602090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Mannion A, Shen Z, Feng Y, Artim SC, Ravindra K, Ge Z, Fox JG. Gamma-glutamyltranspeptidase expression by Helicobacter saguini, an enterohepatic Helicobacter species isolated from cotton top tamarins with chronic colitis. Cell Microbiol 2019;21:e12968. [PMID: 30365223 DOI: 10.1111/cmi.12968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
316 Cozier Y, Ruiz-Narvaez E, McKinnon C, Berman J, Rosenberg L, Palmer J. Replication of genetic loci for sarcoidosis in US black women: data from the Black Women's Health Study. Hum Genet 2013;132:803-10. [PMID: 23543185 DOI: 10.1007/s00439-013-1292-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
317 Zhu T, Liu TJ, Shi YY, Zhao Q. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis. Int J Mol Med 2015;35:1213-8. [PMID: 25813397 DOI: 10.3892/ijmm.2015.2150] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
318 Ciapponi A, Virgilio SA, Berrueta M, Soto NC, Ciganda Á, Rojas Illanes MF, Rubio Martinez B, Gamba J, González Salazar CA, Rocha Rodríguez JN, Scarpellini B, Bravo Perdomo AM, Machnicki G, Aldunate L, De Paula J, Bardach A. Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study. PLoS One 2020;15:e0228256. [PMID: 31986191 DOI: 10.1371/journal.pone.0228256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Ruiz MA, Kaiser Junior RL, Gouvêa Faria MA, de Quadros LG. Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter 2015;37:136-9. [PMID: 25818827 DOI: 10.1016/j.bjhh.2015.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
320 Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol. 2011;9:356-368. [PMID: 21423246 DOI: 10.1038/nrmicro2546] [Cited by in Crossref: 606] [Cited by in F6Publishing: 566] [Article Influence: 55.1] [Reference Citation Analysis]
321 Catanzaro D, Rancan S, Orso G, Dall’Acqua S, Brun P, Giron MC, Carrara M, Castagliuolo I, Ragazzi E, Caparrotta L. Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage. PLoS One. 2015;10:e0125375. [PMID: 25955295 DOI: 10.1371/journal] [Cited by in F6Publishing: 84] [Reference Citation Analysis]
322 Tang X, Yang M, Gu Y, Jiang L, Du Y, Liu J. Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. Drug Des Devel Ther 2021;15:4105-23. [PMID: 34616144 DOI: 10.2147/DDDT.S322702] [Reference Citation Analysis]
323 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
324 Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2011;11:445-456. [PMID: 21681197 DOI: 10.1038/nri3007] [Cited by in Crossref: 368] [Cited by in F6Publishing: 332] [Article Influence: 33.5] [Reference Citation Analysis]
325 Ji Y, Li RP, Wang ML. Progress in understanding the relationship between inflammatory bowel disease and human cytomegalovirus infection. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2070-2074 [DOI: 10.11569/wcjd.v20.i22.2070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
326 Hedl M, Abraham C. Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines. Gastroenterology 2012;143:1530-43. [PMID: 22967725 DOI: 10.1053/j.gastro.2012.08.048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
327 An TJ, Tabari A, Gee MS, McCarthy CJ. Factors influencing cumulative radiation dose from percutaneous intra-abdominal abscess drainage in the setting of inflammatory bowel disease. Abdom Radiol (NY) 2021;46:2195-202. [PMID: 33237341 DOI: 10.1007/s00261-020-02864-1] [Reference Citation Analysis]
328 Dorofeyev AE, Vasilenko IV, Rassokhina OA, Kondratiuk RB. Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol Res Pract 2013;2013:431231. [PMID: 23737764 DOI: 10.1155/2013/431231] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 8.7] [Reference Citation Analysis]
329 Shale M, Schiering C, Powrie F. CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev 2013;252:164-82. [PMID: 23405904 DOI: 10.1111/imr.12039] [Cited by in Crossref: 122] [Cited by in F6Publishing: 114] [Article Influence: 13.6] [Reference Citation Analysis]
330 Wang X, Wang G, Shang J, Pan H, Zhang XA, Zhou F. Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis. J Int Med Res 2019;47:3534-49. [PMID: 31364448 DOI: 10.1177/0300060519864800] [Reference Citation Analysis]
331 Monteleone G, Franzè E, Troncone E, Maresca C, Marafini I. Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut. Front Immunol 2022;13:873332. [DOI: 10.3389/fimmu.2022.873332] [Reference Citation Analysis]
332 Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis 2013;72:1200-5. [PMID: 22941766 DOI: 10.1136/annrheumdis-2012-202143] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 11.7] [Reference Citation Analysis]
333 Weimers P, Munkholm P. The Natural History of IBD: Lessons Learned. Curr Treat Options Gastroenterol 2018;16:101-11. [PMID: 29359275 DOI: 10.1007/s11938-018-0173-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
334 Heim VJ, Stafford CA, Nachbur U. NOD Signaling and Cell Death. Front Cell Dev Biol 2019;7:208. [PMID: 31632962 DOI: 10.3389/fcell.2019.00208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
335 Garg R, Mohan BP, Ponnada S, Regueiro M, Lightner AL, Click B. Postoperative outcomes after preoperative ustekinumab exposure in patients with Crohn's disease: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:691-8. [PMID: 34475740 DOI: 10.20524/aog.2021.0634] [Reference Citation Analysis]
336 Forkel M, Mjösberg J. Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease. Curr Allergy Asthma Rep 2016;16:73. [PMID: 27645534 DOI: 10.1007/s11882-016-0652-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
337 Murdoch TB, Bernstein CN, El-Gabalawy H, Stempak JM, Sargent M, Elias B, Xu W, Pathan S, Silverberg MS. Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort. CMAJ 2012;184:E435-41. [PMID: 22496383 DOI: 10.1503/cmaj.110613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
338 Meunier C, Van Der Kraak L, Turbide C, Groulx N, Labouba I, Cingolani P, Blanchette M, Yeretssian G, Mes-Masson AM, Saleh M, Beauchemin N, Gros P. Positional mapping and candidate gene analysis of the mouse Ccs3 locus that regulates differential susceptibility to carcinogen-induced colorectal cancer. PLoS One 2013;8:e58733. [PMID: 23516545 DOI: 10.1371/journal.pone.0058733] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
339 Cheon SY, Lee JE. Extracellular Vesicles and Immune System in Ageing and Immune Diseases. Exp Neurobiol 2021;30:32-47. [PMID: 33632983 DOI: 10.5607/en20059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Lin L, Zhou G, Chen P, Wang Y, Han J, Chen M, He Y, Zhang S. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? Cell Death Dis 2020;11:456. [PMID: 32541691 DOI: 10.1038/s41419-020-2657-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
341 Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath MF, Atreya R. Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients. Crohns Colitis 360 2020;2:otaa037. [PMID: 32776006 DOI: 10.1093/crocol/otaa037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Wang X, Jiang Y, Zhu Y, Zhang M, Li M, Wang H, Gao P. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis. J Cell Mol Med 2016;20:804-14. [PMID: 26800315 DOI: 10.1111/jcmm.12728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
343 Molendijk I, Duijvestein M, van der Meulen-de Jong AE, van Deen WK, Swets M, Hommes DW, Verspaget HW. Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J Allergy (Cairo) 2012;2012:187408. [PMID: 23049573 DOI: 10.1155/2012/187408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
344 Breynaert C, Dresselaers T, Perrier C, Arijs I, Cremer J, Van Lommel L, Van Steen K, Ferrante M, Schuit F, Vermeire S, Rutgeerts P, Himmelreich U, Ceuppens JL, Geboes K, Van Assche G. Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PLoS One 2013;8:e68876. [PMID: 23894361 DOI: 10.1371/journal.pone.0068876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
345 Dai C, Huang YH, Jiang M, Sun MJ. Nonclostridium difficile enteric infection and the risk of developing inflammatory bowel disease: A systematic review and meta-analysis. Saudi J Gastroenterol 2020. [PMID: 33154203 DOI: 10.4103/sjg.SJG_231_20] [Reference Citation Analysis]
346 Carvalho L, Gomes JRM, Tavares LC, Xavier AR, Klika KD, Holmdahl R, Carvalho RA, Souto-Carneiro MM. Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:701. [PMID: 29867918 DOI: 10.3389/fimmu.2018.00701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
347 Gardenbroek TJ, Pinkney TD, Sahami S, Morton DG, Buskens CJ, Ponsioen CY, Tanis PJ, Löwenberg M, van den Brink GR, Broeders IA, Pullens PH, Seerden T, Boom MJ, Mallant-Hent RC, Pierik RE, Vecht J, Sosef MN, van Nunen AB, van Wagensveld BA, Stokkers PC, Gerhards MF, Jansen JM, Acherman Y, Depla AC, Mannaerts GH, West R, Iqbal T, Pathmakanthan S, Howard R, Magill L, Singh B, Htun Oo Y, Negpodiev D, Dijkgraaf MG, Ram D'Haens G, Bemelman WA. The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019). BMC Surg 2015;15:30. [PMID: 25887789 DOI: 10.1186/s12893-015-0017-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
348 Robinson AM, Miller S, Payne N, Boyd R, Sakkal S, Nurgali K. Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs. PLoS One 2015;10:e0139023. [PMID: 26397368 DOI: 10.1371/journal.pone.0139023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
349 Li J, Chen H, Wang B, Cai C, Yang X, Chai Z, Feng W. ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling. Sci Rep 2017;7:43126. [PMID: 28233796 DOI: 10.1038/srep43126] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
350 Chen H, Lee A, Bowcock A, Zhu W, Li E, Ciorba M, Hunt S. Influence of Crohn's disease risk alleles and smoking on disease location. Dis Colon Rectum 2011;54:1020-5. [PMID: 21730793 DOI: 10.1007/DCR.0b013e31821b94b3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
351 Fransen K, Mitrovic M, van Diemen CC, Weersma RK. The quest for genetic risk factors for Crohn's disease in the post-GWAS era. Genome Med 2011;3:13. [PMID: 21392414 DOI: 10.1186/gm227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
352 Marafini I, Monteleone G. Precision Medicine in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:653924. [PMID: 33927628 DOI: 10.3389/fphar.2021.653924] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 DeBoer MD, Denson LA. Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains. J Pediatr 2013;163:17-22. [PMID: 23522861 DOI: 10.1016/j.jpeds.2013.02.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
354 Catanzaro D, Rancan S, Orso G, Dall'Acqua S, Brun P, Giron MC, Carrara M, Castagliuolo I, Ragazzi E, Caparrotta L, Montopoli M. Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage. PLoS One 2015;10:e0125375. [PMID: 25955295 DOI: 10.1371/journal.pone.0125375] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
355 Mirza AH, Berthelsen CH, Seemann SE, Pan X, Frederiksen KS, Vilien M, Gorodkin J, Pociot F. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med. 2015;7:39. [PMID: 25991924 DOI: 10.1186/s13073-015-0162-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 13.9] [Reference Citation Analysis]
356 Marel SVD, Majowicz A, Deventer SV, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011; 2(6): 114-122 [PMID: 22180846 DOI: 10.4291/wjgp.v2.i6.114] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
357 Lykowska-Szuber L, Walczak M, Skrzypczak-Zielinska M, Suszynska-Zajczyk J, Stawczyk-Eder K, Waszak K, Eder P, Wozniak A, Krela-Kazmierczak I, Slomski R, Dobrowolska A. Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease. Front Immunol 2021;12:615539. [PMID: 33767696 DOI: 10.3389/fimmu.2021.615539] [Reference Citation Analysis]
358 Azer SA, Azer S. What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence. BMJ Open. 2018;8:e021233. [PMID: 30002009 DOI: 10.1136/bmjopen-2017-021233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
359 Xu M, Fan H. Advances in stem cell treatment of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(2): 214-220 [DOI: 10.11569/wcjd.v23.i2.214] [Reference Citation Analysis]
360 Couto MR, Gonçalves P, Catarino TA, Martel F. The Effect of Inflammatory Status on Butyrate and Folate Uptake by Tumoral (Caco-2) and Non-Tumoral (IEC-6) Intestinal Epithelial Cells. Cell J 2017;19:96-105. [PMID: 28580313 DOI: 10.22074/cellj.2017.4859] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
361 Honzawa Y, Matsuura M, Higuchi H, Sakurai T, Seno H, Nakase H. A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis. Endosc Int Open 2020;8:E41-9. [PMID: 31921983 DOI: 10.1055/a-0990-9375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
362 Li WQ, Cho E, Khalili H, Wu S, Chan AT, Qureshi AA. Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women. Clin Gastroenterol Hepatol 2016;14:220-5.e1-3. [PMID: 26404866 DOI: 10.1016/j.cgh.2015.09.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
363 Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 2019;19:550. [PMID: 31196184 DOI: 10.1186/s12889-019-6858-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
364 Fu Y, Ni J, Chen J, Ma G, Zhao M, Zhu S, Shi T, Zhu J, Huang Z, Zhang J, Chen J. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease. Mol Ther 2020;28:1214-28. [PMID: 32087149 DOI: 10.1016/j.ymthe.2020.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
365 Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. PLoS One 2016;11:e0154564. [PMID: 27128484 DOI: 10.1371/journal.pone.0154564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
366 Nettleford SK, Prabhu KS. Selenium and Selenoproteins in Gut Inflammation-A Review. Antioxidants (Basel) 2018;7:E36. [PMID: 29494512 DOI: 10.3390/antiox7030036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
367 Vaghari-Tabari M, Jafari-Gharabaghlou D, Sadeghsoltani F, Hassanpour P, Qujeq D, Rashtchizadeh N, Ghorbanihaghjo A. Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles? Biol Trace Elem Res 2021;199:3190-204. [PMID: 33098076 DOI: 10.1007/s12011-020-02444-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
368 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
369 Ewais T, Begun J, Kenny M, Headey A, Kisely S. Mindfulness-Based Cognitive Therapy Experiences in Youth With Inflammatory Bowel Disease and Depression: Protocol for a Mixed Methods Qualitative Study. JMIR Res Protoc 2019;8:e14432. [PMID: 31342900 DOI: 10.2196/14432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
370 Lopez-Dee ZP, Chittur SV, Patel H, Chinikaylo A, Lippert B, Patel B, Lawler J, Gutierrez LS. Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis. PLoS One 2015;10:e0139918. [PMID: 26461935 DOI: 10.1371/journal.pone.0139918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
371 Pagnini C, Siakavellas SI, Bamias G. Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn's Disease Patients. Gastroenterol Res Pract 2018;2018:6317057. [PMID: 30116266 DOI: 10.1155/2018/6317057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
372 Xu J, Tang M, Shen J. Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade. Gastroenterol Res Pract 2013;2013:267630. [PMID: 24307891 DOI: 10.1155/2013/267630] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
373 Troiano G, Dioguardi M, Giannatempo G, Laino L, Testa NF, Cocchi R, De Lillo A, Lo Muzio L. Orofacial granulomatosis: clinical signs of different pathologies. Med Princ Pract 2015;24:117-22. [PMID: 25592641 DOI: 10.1159/000369810] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
374 Lin GJ, Huang SH, Chen SJ, Wang CH, Chang DM, Sytwu HK. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci 2013;14:11742-66. [PMID: 23727938 DOI: 10.3390/ijms140611742] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
375 Naganuma M, Fujii T, Watanabe M. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease. J Gastroenterol. 2011;46:129-137. [PMID: 21132334 DOI: 10.1007/s00535-010-0352-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
376 Wang J, Wang X, Yang H, Wu D, Wang L, Qian J. Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis. Hum Genet 2011;129:597-609. [PMID: 21279723 DOI: 10.1007/s00439-011-0952-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
377 Kauder SE, Santell L, Mai E, Wright LY, Luis E, N'Diaye EN, Lutman J, Ratti N, Sa SM, Maun HR, Stefanich E, Gonzalez LC, Graham RR, Diehl L, Faubion WA Jr, Keir ME, Young J, Chaudhuri A, Lazarus RA, Egen JG. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele. PLoS One 2013;8:e83958. [PMID: 24409221 DOI: 10.1371/journal.pone.0083958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
378 Ananthakrishnan AN, Huang H, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Differential Effect of Genetic Burden on Disease Phenotypes in Crohn's Disease and Ulcerative Colitis: Analysis of a North American Cohort. American Journal of Gastroenterology 2014;109:395-400. [DOI: 10.1038/ajg.2013.464] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
379 Li J, Zhong W, Wang W, Hu S, Yuan J, Zhang B, Hu T, Song G. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation. PLoS One 2014;9:e87810. [PMID: 24504372 DOI: 10.1371/journal.pone.0087810] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
380 Pringle PL, Stewart KO, Peloquin JM, Sturgeon HC, Nguyen D, Sauk J, Garber JJ, Yajnik V, Ananthakrishnan AN, Chan AT, Xavier RJ, Khalili H. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.Inflamm Bowel Dis. 2015;21:2304-2310. [PMID: 26181430 DOI: 10.1097/MIB.0000000000000498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
381 Blander JM. Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. FEBS J. 2016;283:2720-2730. [PMID: 27250564 DOI: 10.1111/febs.13771] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 13.8] [Reference Citation Analysis]
382 Markovic M, Ben-shabat S, Nagendra Manda J, Abramov-harpaz K, Regev C, Miller Y, Aponick A, Zimmermann EM, Dahan A. PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics 2022;14:675. [DOI: 10.3390/pharmaceutics14030675] [Reference Citation Analysis]
383 Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, Leleiko N, Kenche H, Stolfi A, Wine E. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis. 2012;18:1799-1808. [PMID: 22170749 DOI: 10.1002/ibd.22860] [Cited by in Crossref: 172] [Cited by in F6Publishing: 165] [Article Influence: 15.6] [Reference Citation Analysis]
384 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014;63:776-84. [PMID: 23828881 DOI: 10.1136/gutjnl-2013-305304] [Cited by in Crossref: 225] [Cited by in F6Publishing: 194] [Article Influence: 25.0] [Reference Citation Analysis]
385 Yamamoto-Furusho JK, Sarmiento-Aguilar A. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clin Rheumatol 2018;37:677-82. [PMID: 28914369 DOI: 10.1007/s10067-017-3834-z] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
386 Dulai PS, Levesque BG, Feagan BG, D'Haens G, Sandborn WJ. Assessment of mucosal healing in inflammatory bowel disease: review. Gastrointest Endosc 2015;82:246-55. [PMID: 26005012 DOI: 10.1016/j.gie.2015.03.1974] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
387 Kim SW, Ehrman J, Ahn MR, Kondo J, Lopez AAM, Oh YS, Kim XH, Crawley SW, Goldenring JR, Tyska MJ, Rericha EC, Lau KS. Shear stress induces noncanonical autophagy in intestinal epithelial monolayers. Mol Biol Cell 2017;28:3043-56. [PMID: 28855375 DOI: 10.1091/mbc.E17-01-0021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
388 Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Aliment Pharmacol Ther 2017;46:645-56. [PMID: 28815649 DOI: 10.1111/apt.14253] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 11.4] [Reference Citation Analysis]
389 Law CC, Sasidharan S, Rodrigues R, Nguyen DD, Sauk J, Garber J, Giallourakis C, Xavier R, Khalili H, Yajnik V. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis. 2016;22:2149-2157. [PMID: 27482978 DOI: 10.1097/mib.0000000000000870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
390 Kochar B, Orkaby AR, Ananthakrishnan AN, Ritchie CS. Frailty in inflammatory bowel diseases: an emerging concept. Therap Adv Gastroenterol 2021;14:17562848211025474. [PMID: 34594400 DOI: 10.1177/17562848211025474] [Reference Citation Analysis]
391 Pagnini C, Corleto VD, Martorelli M, Lanini C, D’Ambra G, Di Giulio E, Delle Fave G. Mucosal adhesion and anti-inflammatory effects of Lactobacillus rhamnosus GG in the human colonic mucosa: A proof-of-concept study. World J Gastroenterol 2018; 24(41): 4652-4662 [PMID: 30416313 DOI: 10.3748/wjg.v24.i41.4652] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
392 Hedl M, Yan J, Abraham C. IRF5 and IRF5 Disease-Risk Variants Increase Glycolysis and Human M1 Macrophage Polarization by Regulating Proximal Signaling and Akt2 Activation. Cell Rep 2016;16:2442-55. [PMID: 27545875 DOI: 10.1016/j.celrep.2016.07.060] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
393 Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World J Gastroenterol 2021; 27(2): 162-175 [PMID: 33510557 DOI: 10.3748/wjg.v27.i2.162] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
394 Kamboj AK, Oxentenko AS. Clinical and Histologic Mimickers of Celiac Disease. Clin Transl Gastroenterol 2017;8:e114. [PMID: 28817113 DOI: 10.1038/ctg.2017.41] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
395 Bogach J, Pond G, Eskicioglu C, Simunovic M, Seow H. Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study. J Gastrointest Surg 2021. [PMID: 33559097 DOI: 10.1007/s11605-021-04913-6] [Reference Citation Analysis]
396 Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
397 Campbell EL, Colgan SP. Control and dysregulation of redox signalling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2019;16:106-20. [PMID: 30443019 DOI: 10.1038/s41575-018-0079-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
398 Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med 2012;156:350-9. [PMID: 22393130 DOI: 10.7326/0003-4819-156-5-201203060-00007] [Cited by in Crossref: 142] [Cited by in F6Publishing: 125] [Article Influence: 14.2] [Reference Citation Analysis]
399 Kim SW, Jung YS, Ahn JB, Shin ES, Jang HW, Lee HJ, Il Kim T, Kim DY, Bang D, Kim WH, Cheon JH. Identification of genetic susceptibility loci for intestinal Behçet's disease. Sci Rep 2017;7:39850. [PMID: 28045058 DOI: 10.1038/srep39850] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
400 Kuo CJ, Le PH, Tai WC, Wu KL, Yen HH, Yen CW, Tung SY, Chung CS, Su MY, Chiu CT. The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study. J Formos Med Assoc 2021:S0929-6646(21)00532-5. [PMID: 34924273 DOI: 10.1016/j.jfma.2021.11.012] [Reference Citation Analysis]
401 Dinwiddie DL, Bracken JM, Bass JA, Christenson K, Soden SE, Saunders CJ, Miller NA, Singh V, Zwick DL, Roberts CC, Dalal J, Kingsmore SF. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing. Genomics 2013;102:442-7. [PMID: 24001973 DOI: 10.1016/j.ygeno.2013.08.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
402 Zemel M, Solo E, Tulchinsky H. Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence? Int J Colorectal Dis 2021. [PMID: 33928416 DOI: 10.1007/s00384-021-03941-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Monteleone G, Caruso R, Pallone F. Role of Smad7 in inflammatory bowel diseases. World J Gastroenterol 2012; 18(40): 5664-5668 [PMID: 23155305 DOI: 10.3748/wjg.v18.i40.5664] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
404 Jacobson S. Early postoperative complications in patients with Crohn’s disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol. 2012;47:170-177. [PMID: 22242614 DOI: 10.3109/00365521.2011.648954] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 6.2] [Reference Citation Analysis]
405 Al-Dwairi A, Alqudah TE, Al-Shboul O, Alqudah M, Mustafa AG, Alfaqih MA. Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro. J Inflamm Res 2018;11:95-109. [PMID: 29593427 DOI: 10.2147/JIR.S152835] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
406 Sinagra E, Busacca A, Guida L, Carrozza L, Brinch D, Crispino F, Maida M, Battaglia S, Celsa C, Cammà C, Cappello M. Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data. Gastroenterology Insights 2022;13:117-26. [DOI: 10.3390/gastroent13010013] [Reference Citation Analysis]
407 Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci. 2015;60:1396-1405. [PMID: 25407806 DOI: 10.1007/s10620-014-3437-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
408 Stolfi C, Pallone F, Monteleone G. Colorectal cancer chemoprevention by mesalazine and its derivatives. J Biomed Biotechnol 2012;2012:980458. [PMID: 22701310 DOI: 10.1155/2012/980458] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
409 Tyler CJ, Guzman M, Lundborg LR, Yeasmin S, Perez-Jeldres T, Yarur A, Behm B, Dulai PS, Patel D, Bamias G, Rivera-Nieves J. Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design. J Crohns Colitis 2020;14:1364-77. [PMID: 32239151 DOI: 10.1093/ecco-jcc/jjaa067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11:965-971. [PMID: 23376797 DOI: 10.1016/j.cgh.2013.01.021] [Cited by in Crossref: 115] [Cited by in F6Publishing: 102] [Article Influence: 12.8] [Reference Citation Analysis]
411 Hedl M, Abraham C. IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells. J Immunol. 2012;188:5348-5356. [PMID: 22544929 DOI: 10.4049/jimmunol.1103319] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
412 Liu P, Li Y, Wang R, Ren F, Wang X. Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease. Biomedicines 2022;10:85. [DOI: 10.3390/biomedicines10010085] [Reference Citation Analysis]
413 Zhang YZ, Li YY. Inflammatory bowel disease: Pathogenesis. World J Gastroenterol 2014; 20(1): 91-99 [PMID: 24415861 DOI: 10.3748/wjg.v20.i1.91] [Cited by in CrossRef: 441] [Cited by in F6Publishing: 389] [Article Influence: 55.1] [Reference Citation Analysis]
414 Fernandez-Marcos PJ, Auwerx J, Schoonjans K. Emerging actions of the nuclear receptor LRH-1 in the gut. Biochim Biophys Acta 2011;1812:947-55. [PMID: 21194563 DOI: 10.1016/j.bbadis.2010.12.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
415 Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ. Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. Dig Dis Sci 2012;57:2149-56. [PMID: 22447434 DOI: 10.1007/s10620-012-2128-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
416 Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe. 2014;16:276-289. [PMID: 25211071 DOI: 10.1016/j.chom.2014.08.014] [Cited by in Crossref: 272] [Cited by in F6Publishing: 214] [Article Influence: 38.9] [Reference Citation Analysis]
417 Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, Chan AT. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62:1153-1159. [PMID: 22619368 DOI: 10.1136/gutjnl-2012-302362] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 10.2] [Reference Citation Analysis]
418 Takahara M, Hiraoka S, Ohmori M, Takeuchi K, Takei K, Yasutomi E, Igawa S, Yamamoto S, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Ohnishi H, Okada H. The Colon Wall Thickness Measured Using Transabdominal Ultrasonography is Useful for Detecting Mucosal Inflammation in Ulcerative Colitis. Intern Med . [DOI: 10.2169/internalmedicine.8827-21] [Reference Citation Analysis]
419 de Bruyn M, Sabino J, Vandeputte D, Vermeire S, Raes J, Opdenakker G. Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis. NPJ Biofilms Microbiomes 2018;4:18. [PMID: 30181895 DOI: 10.1038/s41522-018-0059-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
420 VanDussen KL, Liu TC, Li D, Towfic F, Modiano N, Winter R, Haritunians T, Taylor KD, Dhall D, Targan SR. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn’s disease. Gastroenterology. 2014;146:200-209. [PMID: 24076061 DOI: 10.1053/j.gastro.2013.09.048] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 12.2] [Reference Citation Analysis]
421 Bennike TB, Carlsen TG, Ellingsen T, Bonderup OK, Glerup H, Bøgsted M, Christiansen G, Birkelund S, Stensballe A, Andersen V. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies. Inflamm Bowel Dis. 2015;21:2052-2067. [PMID: 25993694 DOI: 10.1097/mib.0000000000000460] [Cited by in Crossref: 74] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
422 Sleutjes JAM, van Lennep JER, van der Woude CJ, de Vries AC. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol 2021;14:17562848211032126. [PMID: 34377149 DOI: 10.1177/17562848211032126] [Reference Citation Analysis]
423 Wang MJ, Xu XL, Yao GL, Yu Q, Zhu CF, Kong ZJ, Zhao H, Tang LM, Qin XH. MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases. Oncotarget 2016;7:58862-75. [PMID: 27556856 DOI: 10.18632/oncotarget.11186] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
424 da Silva LM, de Souza P, Jaouni SKA, Harakeh S, Golbabapour S, de Andrade SF. Propolis and Its Potential to Treat Gastrointestinal Disorders. Evid Based Complement Alternat Med 2018;2018:2035820. [PMID: 29736177 DOI: 10.1155/2018/2035820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
425 Ma L, Shen X, Chen YJ, Zhang Q, Li B, Zhang W. Computed tomography enterography for crohn's disease: correlation between the imaging findings and histopathologic scoring system. Abdom Radiol (NY) 2021;46:4121-9. [PMID: 33993318 DOI: 10.1007/s00261-021-03112-w] [Reference Citation Analysis]
426 Runtsch MC, Round JL, O’Connell RM. MicroRNAs and the regulation of intestinal homeostasis. Front Genet. 2014;5:347. [PMID: 25324861 DOI: 10.3389/fgene.2014.00347] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
427 Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. 2014;146:1564-1572. [PMID: 24503132 DOI: 10.1053/j.gastro.2014.01.058] [Cited by in Crossref: 339] [Cited by in F6Publishing: 291] [Article Influence: 42.4] [Reference Citation Analysis]
428 Yang S, Park JS, Hwang SH, Cho KH, Na HS, Choi J, Jhun J, Kim SJ, Lee BI, Park SH, Cho ML. Metformin-Inducible Small Heterodimer Partner Interacting Leucine Zipper Protein Ameliorates Intestinal Inflammation. Front Immunol 2021;12:652709. [PMID: 34211461 DOI: 10.3389/fimmu.2021.652709] [Reference Citation Analysis]
429 Mohammed Vashist N, Samaan M, Mosli MH, Parker CE, MacDonald JK, Nelson SA, Zou GY, Feagan BG, Khanna R, Jairath V. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev 2018;1:CD011450. [PMID: 29338066 DOI: 10.1002/14651858.CD011450.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
430 Tomar SK, Kedia S, Upadhyay AD, Bopanna S, Yadav DP, Goyal S, Jain S, Makharia G, Ahuja V, Singh N. Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India. JGH Open. 2017;1:15-21. [PMID: 30483527 DOI: 10.1002/jgh3.12002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
431 Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS. The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease. Aliment Pharmacol Ther 2017;46:162-8. [PMID: 28470787 DOI: 10.1111/apt.14125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
432 Zhou H, Zeng X, Sun D, Chen Z, Chen W, Fan L, Limpanont Y, Dekumyoy P, Maleewong W, Lv Z. Monosexual Cercariae of Schistosoma japonicum Infection Protects Against DSS-Induced Colitis by Shifting the Th1/Th2 Balance and Modulating the Gut Microbiota. Front Microbiol 2020;11:606605. [PMID: 33469451 DOI: 10.3389/fmicb.2020.606605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
433 Youssif C, Cubillos-Rojas M, Comalada M, Llonch E, Perna C, Djouder N, Nebreda AR. Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis. EMBO Mol Med 2018;10:e8403. [PMID: 29907597 DOI: 10.15252/emmm.201708403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
434 Hedl M, Abraham C. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages. J Biol Chem. 2011;286:26440-26449. [PMID: 21659536 DOI: 10.1074/jbc.M111.237495] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
435 De Santis S, Verna G, Serino G, Armentano R, Cavalcanti E, Liso M, Dicarlo M, Coletta S, Mastronardi M, Lippolis A, Tafaro A, Santino A, Pinto A, Campiglia P, Huang AY, Cominelli F, Pizarro TT, Chieppa M. Winnie-APCMin/+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation. Int J Mol Sci 2020;21:E2972. [PMID: 32340123 DOI: 10.3390/ijms21082972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
436 Keshteli AH, van den Brand FF, Madsen KL, Mandal R, Valcheva R, Kroeker KI, Han B, Bell RC, Cole J, Hoevers T, Wishart DS, Fedorak RN, Dieleman LA. Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study. World J Gastroenterol 2017; 23(21): 3890-3899 [PMID: 28638229 DOI: 10.3748/wjg.v23.i21.3890] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
437 Ewais T, Begun J, Kenny M, Headey A, Tefay M, Kisely S. Mindfulness-based cognitive therapy experiences in youth with inflammatory bowel disease and depression: findings from a mixed methods qualitative study. BMJ Open 2020;10:e041140. [PMID: 33148766 DOI: 10.1136/bmjopen-2020-041140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
438 Bocchetti M, Ferraro MG, Ricciardiello F, Ottaiano A, Luce A, Cossu AM, Scrima M, Leung WY, Abate M, Stiuso P, Caraglia M, Zappavigna S, Yau TO. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer. Int J Mol Sci 2021;22:3967. [PMID: 33921348 DOI: 10.3390/ijms22083967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
439 Reinecke K, Eminel S, Dierck F, Roessner W, Kersting S, Chromik AM, Gavrilova O, Laukevicience A, Leuschner I, Waetzig V. The JNK inhibitor XG-102 protects against TNBS-induced colitis. PLoS One. 2012;7:e30985. [PMID: 22427801 DOI: 10.1371/journal.pone.0030985] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
440 Kelsen JR, Conrad MA, Dawany N, Patel T, Shraim R, Merz A, Maurer K, Sullivan KE, Devoto M. The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:909-18. [PMID: 31560377 DOI: 10.1093/ibd/izz214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
441 Zhang Y, Li X, Luo Z, Ma L, Zhu S, Wang Z, Wen J, Cheng S, Gu W, Lian Q, Zhao X, Fan W, Ling Z, Ye J, Zheng S, Li D, Wang H, Liu J, Sun B. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation. Proc Natl Acad Sci U S A 2020;117:3083-92. [PMID: 31980528 DOI: 10.1073/pnas.1912774117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
442 Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR. No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC). Eur J Clin Nutr. 2017;71:512-518. [PMID: 28120853 DOI: 10.1038/ejcn.2016.271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
443 Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:187-193. [PMID: 21425211 DOI: 10.1002/ibd.21691] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 9.0] [Reference Citation Analysis]
444 Indellicato R, Trinchera M. Epigenetic Regulation of Glycosylation in Cancer and Other Diseases. Int J Mol Sci 2021;22:2980. [PMID: 33804149 DOI: 10.3390/ijms22062980] [Reference Citation Analysis]
445 Østvik AE, Granlund AV, Torp SH, Flatberg A, Beisvåg V, Waldum HL, Flo TH, Espevik T, Damås JK, Sandvik AK. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin Exp Immunol 2013;173:502-11. [PMID: 23668802 DOI: 10.1111/cei.12136] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
446 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 604] [Article Influence: 94.6] [Reference Citation Analysis]
447 Hilhorst M, Shirai T, Berry G, Goronzy JJ, Weyand CM. T cell-macrophage interactions and granuloma formation in vasculitis. Front Immunol 2014;5:432. [PMID: 25309534 DOI: 10.3389/fimmu.2014.00432] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
448 Uchiyama K, Kishi H, Komatsu W, Nagao M, Ohhira S, Kobashi G. Lipid and Bile Acid Dysmetabolism in Crohn's Disease. J Immunol Res 2018;2018:7270486. [PMID: 30402511 DOI: 10.1155/2018/7270486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
449 Minar P, Jackson K, Tsai YT, Sucharew H, Rosen MJ, Denson LA. Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease. Inflamm Bowel Dis 2017;24:198-208. [PMID: 29272485 DOI: 10.1093/ibd/izx022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
450 Iskandar HN, Dhere T, Farraye FA. Ulcerative Colitis: Update on Medical Management. Curr Gastroenterol Rep. 2015;17:44. [PMID: 26386686 DOI: 10.1007/s11894-015-0466-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
451 Meisinger C, Freuer D. Rheumatoid arthritis and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study. Seminars in Arthritis and Rheumatism 2022. [DOI: 10.1016/j.semarthrit.2022.151992] [Reference Citation Analysis]
452 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014;20:1211-27. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
453 Saber T, Bedran K, Ghandour F, El Khoury M, Bou Khalil R, Farhat S. Results from a retrospective analysis of colonoscopies for Inflammatory bowel disease and colorectal cancer in a Lebanese tertiary care centre. BMJ Open Gastroenterol 2017;4:e000167. [PMID: 29018541 DOI: 10.1136/bmjgast-2017-000167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
454 Dai W, Zhan X, Peng W, Liu X, Peng W, Mei Q, Hu X. Ficus pandurata Hance Inhibits Ulcerative Colitis and Colitis-Associated Secondary Liver Damage of Mice by Enhancing Antioxidation Activity. Oxid Med Cell Longev 2021;2021:2617881. [PMID: 34966476 DOI: 10.1155/2021/2617881] [Reference Citation Analysis]
455 Alam MT, Amos GCA, Murphy ARJ, Murch S, Wellington EMH, Arasaradnam RP. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathog 2020;12:1. [PMID: 31911822 DOI: 10.1186/s13099-019-0341-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 32.5] [Reference Citation Analysis]
456 Shi L, Zhang P, Jin R, Chen X, Dong L, Chen W. Dioscin ameliorates inflammatory bowel disease by up-regulating miR-125a-5p to regulate macrophage polarization. J Clin Lab Anal 2022;:e24455. [PMID: 35524480 DOI: 10.1002/jcla.24455] [Reference Citation Analysis]
457 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Richter JM, Schernhammer ES, Chan AT. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1879-1886. [PMID: 24780288 DOI: 10.1016/j.cgh.2014.04.021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
459 Hwang JH, Kim TH, Kim YH, Noh JR, Choi DH, Kim KS, Lee EY, Kim BC, Kim MH, Kim H, Lee TG, Lee JS, Lee CH. Gadd45β promotes regeneration after injury through TGFβ-dependent restitution in experimental colitis. Exp Mol Med 2019;51:1-14. [PMID: 31666502 DOI: 10.1038/s12276-019-0335-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
460 Li H, Wang F, Yang M, Sun J, Zhao Y, Tang D. The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity. Int J Endocrinol 2021;2021:6572342. [PMID: 33790964 DOI: 10.1155/2021/6572342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
461 Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Lindgren S, Grip O, Bergmann MM, Boeing H, Hallmans G. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn’s disease. Aliment Pharmacol Ther. 2014;39:834-842. [PMID: 24611981 DOI: 10.1111/apt.12670] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
462 Wang G, Hiramoto K, Ma N, Yoshikawa N, Ohnishi S, Murata M, Kawanishi S. Glycyrrhizin Attenuates Carcinogenesis by Inhibiting the Inflammatory Response in a Murine Model of Colorectal Cancer. Int J Mol Sci 2021;22:2609. [PMID: 33807620 DOI: 10.3390/ijms22052609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
463 Wang JQ, Huang Y. Serological markers of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4110-4115 [DOI: 10.11569/wcjd.v21.i36.4110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
464 Dobie R, MacRae VE, Pass C, Milne EM, Ahmed SF, Farquharson C. Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease. Dis Model Mech 2018;11:dmm028456. [PMID: 29343614 DOI: 10.1242/dmm.028456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
465 Kim GH, Lee YC, Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH. Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study. J Crohns Colitis 2021:jjab162. [PMID: 34499125 DOI: 10.1093/ecco-jcc/jjab162] [Reference Citation Analysis]
466 Tsai SY, Chen HJ, Lio CF, Kuo CF, Kao AC, Wang WS, Yao WC, Chen C, Yang TY. Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study. J Transl Med 2019;17:55. [PMID: 30795765 DOI: 10.1186/s12967-019-1797-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
467 Vaughn BP, Kaiser T, Staley C, Hamilton MJ, Reich J, Graiziger C, Singroy S, Kabage AJ, Sadowsky MJ, Khoruts A. A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis. Clin Exp Gastroenterol. 2019;12:9-19. [PMID: 30666146 DOI: 10.2147/ceg.s186097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
468 Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350-359. [PMID: 22393130 DOI: 10.1059/0003-4819-156-5-201203060-00007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
469 Kathiria AS, Neumann WL, Rhees J, Hotchkiss E, Cheng Y, Genta RM, Meltzer SJ, Souza RF, Theiss AL. Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses. Cancer Res. 2012;72:5778-5789. [PMID: 22869582 DOI: 10.1158/0008-5472.can-12-0603] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
470 Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol. 2011;9:356-368. [PMID: 21423246 DOI: 10.1038/nrmicro2546.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
471 Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P. IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol. 2014;7:124-133. [PMID: 23695510 DOI: 10.1038/mi.2013.31] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 9.7] [Reference Citation Analysis]
472 Stevens BW, Borren NZ, Velonias G, Conway G, Cleland T, Andrews E, Khalili H, Garber JG, Xavier RJ, Yajnik V, Ananthakrishnan AN. Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci 2017;62:197-206. [PMID: 27796768 DOI: 10.1007/s10620-016-4356-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
473 Tong M, Li X, Wegener Parfrey L, Roth B, Ippoliti A, Wei B, Borneman J, McGovern DP, Frank DN, Li E. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One. 2013;8:e80702. [PMID: 24260458 DOI: 10.1371/journal.pone.0080702] [Cited by in Crossref: 108] [Cited by in F6Publishing: 105] [Article Influence: 12.0] [Reference Citation Analysis]
474 Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol 2018;18:19-34. [PMID: 28944771 DOI: 10.1038/nri.2017.99] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 34.2] [Reference Citation Analysis]
475 O'Neill S, Brault J, Stasia MJ, Knaus UG. Genetic disorders coupled to ROS deficiency. Redox Biol. 2015;6:135-156. [PMID: 26210446 DOI: 10.1016/j.redox.2015.07.009] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 11.9] [Reference Citation Analysis]
476 Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202-210. [PMID: 23334898 DOI: 10.1007/s12016-012-8351-x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
477 Wong J, Garcia-Carbonell R, Zelic M, Ho SB, Boland BS, Yao SJ, Desai SA, Das S, Planell N, Harris PA, Font-Burgada J, Taniguchi K, Bertin J, Salas A, Pasparakis M, Gough PJ, Kelliher M, Karin M, Guma M. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation. Cell Mol Gastroenterol Hepatol 2020;9:295-312. [PMID: 31606566 DOI: 10.1016/j.jcmgh.2019.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
478 Khoshnevisan R, Anderson M, Babcock S, Anderson S, Illig D, Marquardt B, Sherkat R, Schröder K, Moll F, Hollizeck S, Rohlfs M, Walz C, Adibi P, Rezaei A, Andalib A, Koletzko S, Muise AM, Snapper SB, Klein C, Thiagarajah JR, Kotlarz D. NOX1 Regulates Collective and Planktonic Cell Migration: Insights From Patients With Pediatric-Onset IBD and NOX1 Deficiency. Inflamm Bowel Dis 2020;26:1166-76. [PMID: 32064493 DOI: 10.1093/ibd/izaa017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
479 Nemati S, Teimourian S. An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets. Middle East J Dig Dis. 2017;9:69-80. [PMID: 28638582 DOI: 10.15171/mejdd.2017.54] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
480 Wang SY, Zhao JM, Zhou CL, Zheng HD, Huang Y, Zhao M, Zhang ZY, Wu LY, Wu HG, Liu HR. Herbal cake-partitioned moxibustion inhibits colonic autophagy in Crohn’s disease via signaling involving distinct classes of phosphatidylinositol 3-kinases. World J Gastroenterol 2020; 26(39): 5997-6014 [PMID: 33132650 DOI: 10.3748/wjg.v26.i39.5997] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
481 Gorkiewicz G, Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Archiv : an international journal of pathology. 2018;472:159-172. [PMID: 29243124 DOI: 10.1007/s00428-017-2277-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
482 Viganò CA, Beltrami MM, Bosi MF, Zanello R, Valtorta M, Maconi G. Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies. Front Psychiatry 2018;9:324. [PMID: 30127753 DOI: 10.3389/fpsyt.2018.00324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
483 Larussa T, Imeneo M, Luzza F. Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better. Int J Mol Sci 2019;20:E1390. [PMID: 30897691 DOI: 10.3390/ijms20061390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
484 Molloy MJ, Grainger JR, Bouladoux N, Hand TW, Koo LY, Naik S, Quinones M, Dzutsev AK, Gao JL, Trinchieri G, Murphy PM, Belkaid Y. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 2013;14:318-28. [PMID: 24034617 DOI: 10.1016/j.chom.2013.08.003] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 11.5] [Reference Citation Analysis]
485 Talapka P, Nagy LI, Pál A, Poles MZ, Berkó A, Bagyánszki M, Puskás LG, Fekete &, Bódi N. Alleviated mucosal and neuronal damage in a rat model of Crohn’s disease. World J Gastroenterol 2014; 20(44): 16690-16697 [PMID: 25469038 DOI: 10.3748/wjg.v20.i44.16690] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
486 Kayal M, Shah S. Ulcerative Colitis: Current and Emerging Treatment Strategies. J Clin Med 2019;9:E94. [PMID: 31905945 DOI: 10.3390/jcm9010094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
487 Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ 2013;347:f6633. [PMID: 24231178 DOI: 10.1136/bmj.f6633] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
488 Lv H, Jiang Y, Li J, Zhang M, Shang Z, Zheng J, Wu X, Liu P, Zhang R, Yu H. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease. Mol Biol Rep 2014;41:1299-310. [PMID: 24407599 DOI: 10.1007/s11033-013-2975-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
489 Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol. 2011;9:254-264. [PMID: 21407242 DOI: 10.1038/nrmicro2541] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 8.1] [Reference Citation Analysis]
490 Lu XC, Tao Y, Wu C, Zhao PL, Li K, Zheng JY, Li LX. Association between variants of the autophagy related gene--IRGM and susceptibility to Crohn’s disease and ulcerative colitis: a meta-analysis. PLoS One. 2013;8:e80602. [PMID: 24232856 DOI: 10.1371/journal.pone.0080602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
491 Barberio B, Cingolani L, Canova C, Barbieri G, Sablich R, Urbano MT, Bertani L, Costa F, Bodini G, Demarzo MG, Ferronato A, Buda A, Melatti P, Massimi D, Savarino EV, Zingone F. A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study. Therap Adv Gastroenterol 2021;14:17562848211031420. [PMID: 34349836 DOI: 10.1177/17562848211031420] [Reference Citation Analysis]
492 Ranjan K, Hedl M, Sinha S, Zhang X, Abraham C. Ubiquitination of ATF6 by disease-associated RNF186 promotes the innate receptor-induced unfolded protein response. J Clin Invest 2021;131:e145472. [PMID: 34623328 DOI: 10.1172/JCI145472] [Reference Citation Analysis]
493 Johnston A, Natarajan S, Hayes M, MacDonald E, Shorr R. Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol. BMJ Open 2018;8:e019909. [PMID: 29382683 DOI: 10.1136/bmjopen-2017-019909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
494 Shaw AL, Tomanelli A, Bradshaw TP, Petschow BW, Burnett BP. Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective. Patient Prefer Adherence 2017;11:1001-7. [PMID: 28615929 DOI: 10.2147/PPA.S134792] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
495 Papadimitriou K. Effect of resistance exercise training on Crohn's disease patients. Intest Res 2021;19:275-81. [PMID: 33207853 DOI: 10.5217/ir.2020.00043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
496 Vadstrup K, Galsgaard ED, Gerwien J, Vester-Andersen MK, Pedersen JS, Rasmussen J, Neermark S, Kiszka-Kanowitz M, Jensen T, Bendtsen F. Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects. PLoS One 2016;11:e0155335. [PMID: 27171179 DOI: 10.1371/journal.pone.0155335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
497 Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther 2018;48:933-40. [PMID: 30126019 DOI: 10.1111/apt.14951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
498 Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, Yu B, Patel SA, Louis TL, Tysl T, Kurd NS, Bortnick A, Quezada LK, Kanbar JN, Miralles A, Huylebroeck D, Valasek MA, Dulai PS, Singh S, Lu LF, Bui JD, Murre C, Sandborn WJ, Goldrath AW, Yeo GW, Chang JT. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol 2020;5:eabb4432. [PMID: 32826341 DOI: 10.1126/sciimmunol.abb4432] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
499 Tschurtschenthaler M, Adolph TE. The Selective Autophagy Receptor Optineurin in Crohn's Disease. Front Immunol 2018;9:766. [PMID: 29692785 DOI: 10.3389/fimmu.2018.00766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
500 Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int 2014;2014:567929. [PMID: 25580435 DOI: 10.1155/2014/567929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
501 Gareb B, Posthumus S, Beugeling M, Koopmans P, Touw DJ, Dijkstra G, Kosterink JGW, Frijlink HW. Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process. Pharmaceutics 2019;11:E428. [PMID: 31450748 DOI: 10.3390/pharmaceutics11090428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
502 Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 2015; 7(3): 556-567 [PMID: 25914763 DOI: 10.4252/wjsc.v7.i3.556] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
503 Sohn JJ, Schetter AJ, Yfantis HG, Ridnour LA, Horikawa I, Khan MA, Robles AI, Hussain SP, Goto A, Bowman ED, Hofseth LJ, Bartkova J, Bartek J, Wogan GN, Wink DA, Harris CC. Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease. PLoS One 2012;7:e44156. [PMID: 22970173 DOI: 10.1371/journal.pone.0044156] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
504 Chabod M, Pedros C, Lamouroux L, Colacios C, Bernard I, Lagrange D, Balz-Hara D, Mosnier JF, Laboisse C, Vergnolle N. A spontaneous mutation of the rat Themis gene leads to impaired function of regulatory T cells linked to inflammatory bowel disease. PLoS Genet. 2012;8:e1002461. [PMID: 22275874 DOI: 10.1371/journal.pgen.1002461] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
505 Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, Liu Q, Li K, Wang W, Wang H, Xie W, Wang Q, Liu J, Zheng B, Zhang P, Huang S, Shi T, Zhang B, Dang Y, Chen J, O'Malley BW, Moses RE, Wang P, Li L, Xiao J, Hoffmann A, Li X. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun 2016;7:10761. [PMID: 26899380 DOI: 10.1038/ncomms10761] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
506 Christophi GP, Rong R, Holtzapple PG, Massa PT, Landas SK. Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2012;18:2342-2356. [PMID: 22467146 DOI: 10.1002/ibd.22957] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 8.0] [Reference Citation Analysis]
507 Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis. 2016;22:2182-2190. [PMID: 27542133 DOI: 10.1097/mib.0000000000000893] [Cited by in Crossref: 114] [Cited by in F6Publishing: 63] [Article Influence: 28.5] [Reference Citation Analysis]
508 Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, Wu K, Chan AT. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 2015;21:2311-9. [PMID: 26236952 DOI: 10.1097/MIB.0000000000000501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
509 Voskens CJ, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, Wunder J, Siegmund B, Schuler-Thurner B, Schuler G, Berking C, Atreya R, Neurath MF. Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial. BMJ Open 2021;11:e049208. [PMID: 34880013 DOI: 10.1136/bmjopen-2021-049208] [Reference Citation Analysis]
510 Ho SSC, Keenan JI, Day AS. Parent Perspectives of Diagnostic and Monitoring Tests Undertaken by Their Child with Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2021;24:19-29. [PMID: 33505890 DOI: 10.5223/pghn.2021.24.1.19] [Reference Citation Analysis]
511 Conley S, Proctor DD, Lehner V, Jeon S, Redeker NS. The Feasibility of Measuring Sleep and Circadian Characteristics in Adults with Inflammatory Bowel Disease. West J Nurs Res 2020;43:53-9. [PMID: 32517546 DOI: 10.1177/0193945920933926] [Reference Citation Analysis]
512 Wei Y, Gong J, Zhu W, Tian H, Ding C, Gu L, Li N, Li J. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016;16:255. [PMID: 27809778 DOI: 10.1186/s12866-016-0869-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
513 Neumann H, Vieth M, Langner C, Neurath MF, Mudter J. Cancer risk in IBD: How to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011; 17(27): 3184-3191 [PMID: 21912466 DOI: 10.3748/wjg.v17.i27.3184] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
514 Minami N, Matsuura M, Koshikawa Y, Yamada S, Honzawa Y, Yamamoto S, Nakase H. Maternal and fetal outcomes in pregnant Japanese women with inflammatory bowel disease: our experience with a series of 23 cases. Intest Res 2017;15:90-6. [PMID: 28239318 DOI: 10.5217/ir.2017.15.1.90] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
515 Schneider Y, Lichtenstein GR. Postoperative Crohn's disease management: still learning and evolving. Gastrointest Endosc 2019;90:276-7. [PMID: 31327339 DOI: 10.1016/j.gie.2019.04.208] [Reference Citation Analysis]
516 Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012;33:459-466. [PMID: 22677185 DOI: 10.1016/j.it.2012.05.003] [Cited by in Crossref: 188] [Cited by in F6Publishing: 173] [Article Influence: 18.8] [Reference Citation Analysis]
517 Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M. Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease. Dis Markers 2016;2016:6485343. [PMID: 27965521 DOI: 10.1155/2016/6485343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
518 Agrawal T, Acquah I, Dey AK, Glassner K, Abraham B, Blankstein R, Virani SS, Blaha MJ, Valero-Elizondo J, Mehta N, Quigley EM, Cainzos-Achirica M, Nasir K. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease. Am J Prev Cardiol 2021;6:100171. [PMID: 34327497 DOI: 10.1016/j.ajpc.2021.100171] [Reference Citation Analysis]
519 Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH. Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels. NPJ Genom Med 2017;2:3. [PMID: 29263823 DOI: 10.1038/s41525-016-0001-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
520 Arase S, Watanabe Y, Setoyama H, Nagaoka N, Kawai M, Matsumoto S. Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics? PLoS One 2016;11:e0160736. [PMID: 27500935 DOI: 10.1371/journal.pone.0160736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
521 Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF. Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 2015;1:462-76. [PMID: 26393237 DOI: 10.1016/j.jcmgh.2015.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
522 Sacoor C, Barros LM, Montezinho L. What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies? Open Vet J 2021;10:412-30. [PMID: 33614437 DOI: 10.4314/ovj.v10i4.9] [Reference Citation Analysis]
523 Billiet T, Ferrante M, Van Assche G. The use of prognostic factors in inflammatory bowel diseases. Curr Gastroenterol Rep. 2014;16:416. [PMID: 25262067 DOI: 10.1007/s11894-014-0416-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
524 Khalili H, Ananthakrishnan AN, Konijeti GG, Higuchi LM, Fuchs CS, Richter JM, Tworoger SS, Hankinson SE, Chan AT. Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflamm Bowel Dis 2015;21:1378-85. [PMID: 25844961 DOI: 10.1097/MIB.0000000000000385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
525 Bartels LE, Jørgensen SP, Bendix M, Hvas CL, Agnholt J, Agger R, Dahlerup JF. 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease. Inflammopharmacology 2013;21:177-86. [PMID: 23341164 DOI: 10.1007/s10787-012-0168-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
526 Deboer MD. Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. Int J Pept. 2011;2011:189242. [PMID: 21845198 DOI: 10.1155/2011/189242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
527 Thorsteinsdottir S, Gudjonsson T, Nielsen OH, Vainer B, Seidelin JB. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. Nat Rev Gastroenterol Hepatol. 2011;8:395-404. [PMID: 21647200 DOI: 10.1038/nrgastro.2011.96] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
528 Ananthakrishnan AN, Xavier RJ. How does genotype influence disease phenotype in inflammatory bowel disease? Inflamm Bowel Dis 2013;19:2021-30. [PMID: 23644824 DOI: 10.1097/MIB.0b013e318281f5c5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
529 Hedl M, Proctor DD, Abraham C. JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages. J Immunol. 2016;197:3695-3704. [PMID: 27664279 DOI: 10.4049/jimmunol.1600845] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
530 Kesselring R, Fichtner-Feigl S. Immune responses triggering colitis and colitis-associated carcinoma. Langenbecks Arch Surg 2012;397:527-33. [PMID: 22382701 DOI: 10.1007/s00423-012-0927-7] [Reference Citation Analysis]
531 Messina V, Buccione C, Marotta G, Ziccheddu G, Signore M, Mattia G, Puglisi R, Sacchetti B, Biancone L, Valtieri M. Gut Mesenchymal Stromal Cells in Immunity. Stem Cells Int 2017;2017:8482326. [PMID: 28337224 DOI: 10.1155/2017/8482326] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
532 Zulqarnain M, Deepak P, Yarur AJ. Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease. JCM 2022;11:1813. [DOI: 10.3390/jcm11071813] [Reference Citation Analysis]
533 Wang R, Yao Q, Chen W, Gao F, Li P, Wu J, Yu J, Cao H. Stem cell therapy for Crohn's disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021;12:463. [PMID: 34407875 DOI: 10.1186/s13287-021-02533-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
534 Lu X, Tang L, Li K, Zheng J, Zhao P, Tao Y, Li LX. Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects. Sci Rep 2014;4:3924. [PMID: 24473197 DOI: 10.1038/srep03924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
535 Sajjadi M, Gholamrezaei A, Daryani NE. No association between serum adenosine deaminase activity and disease activity in Crohn's disease. Dig Dis Sci. 2015;60:1755-1760. [PMID: 25652144 DOI: 10.1007/s10620-014-3510-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
536 Park TY, Jang Y, Kim W, Shin J, Toh HT, Kim CH, Yoon HS, Leblanc P, Kim KS. Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases. Sci Rep 2019;9:15559. [PMID: 31664129 DOI: 10.1038/s41598-019-52085-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
537 Grüner N, Mattner J. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis. Int J Mol Sci 2021;22:1397. [PMID: 33573273 DOI: 10.3390/ijms22031397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
538 Dillman JR, Rubin JM, Johnson LA, Moons DS, Higgins PD. Can Contrast-Enhanced Sonography Detect Bowel Wall Fibrosis in Mixed Inflammatory and Fibrotic Crohn Disease Lesions in an Animal Model? J Ultrasound Med 2017;36:523-30. [PMID: 28072481 DOI: 10.7863/ultra.16.04064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
539 Yu T, Chu S, Liu X, Li J, Chen Q, Xu M, Wu H, Li M, Dong Y, Zhu F, Zhou H, Hu D, Fan H. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Res Ther 2021;12:181. [PMID: 33722292 DOI: 10.1186/s13287-021-02232-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
540 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
541 van Driel B, Liao G, Romero X, O'Keeffe MS, Wang G, Faubion WA, Berger SB, Magelky EM, Manocha M, Azcutia V, Grisham M, Luscinskas FW, Mizoguchi E, de Waal Malefyt R, Reinecker HC, Bhan AK, Wang N, Terhorst C. Signaling lymphocyte activation molecule regulates development of colitis in mice. Gastroenterology 2012;143:1544-1554.e7. [PMID: 22960654 DOI: 10.1053/j.gastro.2012.08.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
542 Lachaine J, Yen L, Beauchemin C, Hodgkins P. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterol 2013;13:23. [PMID: 23363459 DOI: 10.1186/1471-230X-13-23] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
543 Danielak A, Wojcik D, Mazur-Bialy A, Surmiak M, Bilski J, Targosz A, Magierowski M, Chmura A, Strzalka M, Krzysiek-Maczka G, Magierowska K, Szczyrk U, Kwiecien S, Ptak-Belowska A, Brzozowski T. Intestinal Alkaline Phosphatase Combined with Voluntary Physical Activity Alleviates Experimental Colitis in Obese Mice. Involvement of Oxidative Stress, Myokines, Adipokines and Proinflammatory Biomarkers. Antioxidants (Basel) 2021;10:240. [PMID: 33557311 DOI: 10.3390/antiox10020240] [Reference Citation Analysis]
544 Khanna R, Ma C, Jairath V, Vande Casteele N, Zou G, Feagan BG. Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31674-8. [PMID: 33338657 DOI: 10.1016/j.cgh.2020.12.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
545 Adar T, Faleck D, Sasidharan S, Cushing K, Borren NZ, Nalagatla N, Ungaro R, Sy W, Owen SC, Patel A, Cohen BL, Ananthakrishnan AN. Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. Aliment Pharmacol Ther 2019;49:873-9. [PMID: 30773667 DOI: 10.1111/apt.15177] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
546 Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis. 2012;18:1777-1784. [PMID: 22359410 DOI: 10.1002/ibd.22929] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
547 Seinen ML, van Nieuw Amerongen GP, de Boer NK, van Bodegraven AA. Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy. Mol Diagn Ther 2016;20:551-7. [PMID: 27604084 DOI: 10.1007/s40291-016-0232-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
548 Kim KH, Won JH, Cheng N, Lau LF. The matricellular protein CCN1 in tissue injury repair. J Cell Commun Signal 2018;12:273-9. [PMID: 29357009 DOI: 10.1007/s12079-018-0450-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
549 Woelflingseder L, Gruber N, Adam G, Marko D. Pro-Inflammatory Effects of NX-3 Toxin Are Comparable to Deoxynivalenol and not Modulated by the Co-Occurring Pro-Oxidant Aurofusarin. Microorganisms 2020;8:E603. [PMID: 32326355 DOI: 10.3390/microorganisms8040603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
550 Granlund Av, Flatberg A, Østvik AE, Drozdov I, Gustafsson BI, Kidd M, Beisvag V, Torp SH, Waldum HL, Martinsen TC. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn’s disease and ulcerative colitis. PLoS One. 2013;8:e56818. [PMID: 23468882 DOI: 10.1371/journal.pone.0056818] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
551 Mijac D, Vukovic-Petrovic I, Mijac V, Perovic V, Milic N, Djuranovic S, Bojic D, Popovic D, Culafic D, Krstic M, Jankovic G, Pravica V, Markovic M. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PLoS One 2018;13:e0194536. [PMID: 29543864 DOI: 10.1371/journal.pone.0194536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
552 Ananthakrishnan AN, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:783-789. [PMID: 24651583 DOI: 10.1097/mib.0000000000000014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
553 Hirche TO, Stein J, Hirche H, Hausmann J, Wagner TO, Behrens F, Schröder O. Increased levels of anti-glycan antibodies in patients with cystic fibrosis. Eur J Med Res 2011;16:385-90. [PMID: 22024437 DOI: 10.1186/2047-783x-16-9-385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
554 Pham Ba VA, Han YM, Cho Y, Kim T, Lee BY, Kim JS, Hong S. Modified Floating Electrode-Based Sensors for the Quantitative Monitoring of Drug Effects on Cytokine Levels Related with Inflammatory Bowel Diseases. ACS Appl Mater Interfaces 2018;10:17100-6. [DOI: 10.1021/acsami.8b04287] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
555 Pantazi E, Powell N. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! Front Immunol 2019;10:676. [PMID: 31024537 DOI: 10.3389/fimmu.2019.00676] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
556 Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, Nakayama Y, Tanaka M, Hoshino A, Kanegane H. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study. J Clin Immunol. 2017;37:67-79. [PMID: 27747465 DOI: 10.1007/s10875-016-0339-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
557 Pizarro TT, Pastorelli L, Bamias G, Garg RR, Reuter BK, Mercado JR, Chieppa M, Arseneau KO, Ley K, Cominelli F. SAMP1/YitFc mouse strain: a spontaneous model of Crohn’s disease-like ileitis. Inflamm Bowel Dis. 2011;17:2566-2584. [PMID: 21557393 DOI: 10.1002/ibd.21638] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 9.0] [Reference Citation Analysis]
558 Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 2016;9:567-582. [PMID: 26931062 DOI: 10.1038/mi.2016.14] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
559 Koc A, Bargen I, Suwandi A, Roderfeld M, Tschuschner A, Rath T, Gerlach GF, Hornef M, Goethe R, Weiss S, Roeb E. Systemic and mucosal immune reactivity upon Mycobacterium avium ssp. paratuberculosis infection in mice. PLoS One 2014;9:e94624. [PMID: 24728142 DOI: 10.1371/journal.pone.0094624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
560 Abraham C, Dulai PS, Vermeire S, Sandborn WJ. Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases. Gastroenterology 2017;152:374-388.e4. [PMID: 27780712 DOI: 10.1053/j.gastro.2016.10.018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 12.0] [Reference Citation Analysis]
561 Dmochowska N, Tieu W, Keller MD, Wardill HR, Mavrangelos C, Campaniello MA, Takhar P, Hughes PA. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis. J Nucl Med 2019;60:858-63. [PMID: 30413657 DOI: 10.2967/jnumed.118.219287] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
562 de Alencar Junior H, Paiotti APR, de Araújo Filho HB, Oshima CTF, Miszputen SJ, Ambrogini-Júnior O. The relationship between the commensal microbiota levels and Crohn's disease activity. JGH Open 2020;4:784-9. [PMID: 33102745 DOI: 10.1002/jgh3.12338] [Reference Citation Analysis]
563 Sanjo H, Tokumaru S, Akira S, Taki S. Conditional Deletion of TAK1 in T Cells Reveals a Pivotal Role of TCRαβ+ Intraepithelial Lymphocytes in Preventing Lymphopenia-Associated Colitis. PLoS One 2015;10:e0128761. [PMID: 26132627 DOI: 10.1371/journal.pone.0128761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
564 Moein S, Qujeq D, Vaghari Tabari M, Kashifard M, Hajian-Tilaki K. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. Caspian J Intern Med 2017;8:178-82. [PMID: 28932369 DOI: 10.22088/cjim.8.3.178] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
565 Kimura K, Yoshida A, Katagiri F, Takayanagi R, Yamada Y. Prediction of clinical effects of infliximab administered for inflammatory bowel disease based on pharmacokinetic and pharmacodynamic modeling. Biopharm Drug Dispos 2019;40:250-61. [PMID: 31256430 DOI: 10.1002/bdd.2198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
566 Dulai PS, Mosli M, Khanna R, Levesque BG, Sandborn WJ, Feagan BG. Vedolizumab for the treatment of moderately to severely active ulcerative colitis. Pharmacotherapy 2015;35:412-23. [PMID: 25884529 DOI: 10.1002/phar.1561] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
567 Fung QM, Szilagyi A. Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam 2012;2012:493717. [PMID: 22518336 DOI: 10.1155/2012/493717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
568 Tsuboi K, Nishitani M, Takakura A, Imai Y, Komatsu M, Kawashima H. Autophagy Protects against Colitis by the Maintenance of Normal Gut Microflora and Secretion of Mucus. J Biol Chem 2015;290:20511-26. [PMID: 26149685 DOI: 10.1074/jbc.M114.632257] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
569 Shapiro JM, Zoega H, Shah SA, Bright RM, Mallette M, Moniz H, Grabert SA, Bancroft B, Merrick M, Flowers NT, Samad Z, Lidofsky S, LeLeiko NS, Sands BE. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry. Inflamm Bowel Dis 2016;22:1456-61. [PMID: 26926039 DOI: 10.1097/MIB.0000000000000745] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
570 Marafini I, Monteleone G. Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases. Biologics 2020;14:47-51. [PMID: 32606588 DOI: 10.2147/BTT.S257638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
571 Cengiz D, Gürçay E, Karaahmet ÖZ, Karaahmet F, Umay E, Çakcı A. Inflammatory arthritis complicated by inflammatory bowel disease: two case reports. Turk J Phys Med Rehabil 2017;63:266-71. [PMID: 31453464 DOI: 10.5606/tftrd.2017.23169] [Reference Citation Analysis]
572 Lu D, Liu L, Ji X, Gao Y, Chen X, Liu Y, Liu Y, Zhao X, Li Y, Li Y, Jin Y, Zhang Y, McNutt MA, Yin Y. The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation. Nat Immunol. 2015;16:1263-1273. [PMID: 26479789 DOI: 10.1038/ni.3278] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
573 Spekhorst LM, Visschedijk MC, Alberts R, Festen EA, van der Wouden EJ, Dijkstra G, (ICC) RKWDIOCAC. Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol 2014; 20(41): 15374-15381 [PMID: 25386087 DOI: 10.3748/wjg.v20.i41.15374] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
574 Zhang HS, Chen Y, Fan L, Xi QL, Wu GH, Li XX, Yuan TL, He SQ, Yu Y, Shao ML, Liu Y, Bai CG, Ling ZQ, Li M, Liu Y, Fang J. The Endoplasmic Reticulum Stress Sensor IRE1α in Intestinal Epithelial Cells Is Essential for Protecting against Colitis. J Biol Chem 2015;290:15327-36. [PMID: 25925952 DOI: 10.1074/jbc.M114.633560] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
575 Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010;16:1583-1597. [PMID: 20803699 DOI: 10.1002/ibd.21282] [Cited by in Crossref: 222] [Cited by in F6Publishing: 211] [Article Influence: 18.5] [Reference Citation Analysis]
576 Żyła E, Dziendzikowska K, Kamola D, Wilczak J, Sapierzyński R, Harasym J, Gromadzka-Ostrowska J. Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects. Int J Mol Sci 2021;22:4485. [PMID: 33923129 DOI: 10.3390/ijms22094485] [Reference Citation Analysis]
577 Dave M, Menghini P, Sugi K, Somoza RA, Lee Z, Jain M, Caplan A, Cominelli F. Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases. J Vis Exp 2017. [PMID: 28892033 DOI: 10.3791/55367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
578 Bellavia M, Tomasello G, Romeo M, Damiani P, Lo Monte AI, Lozio L, Campanella C, Marino Gammazza A, Rappa F, Zummo G. Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol. 2013;202:393-406. [PMID: 23864544 DOI: 10.1007/s00430-013-0305-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
579 Chen H, Xia Y, Zhu S, Yang J, Yao J, Di J, Liang Y, Gao R, Wu W, Yang Y. Lactobacillus plantarum LPOnlly alters the gut flora and attenuates colitis by inducing microbiome alteration in interleukin10 knockout mice. Mol Med Rep. 2017;16:5979-5985. [PMID: 28849048 DOI: 10.3892/mmr.2017.7351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
580 Zhang J, Wu J, Peng X, Song J, Wang J, Dong W. Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis. PLoS One. 2014;9:e109625. [PMID: 25286337 DOI: 10.1371/journal.pone.0109625] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
581 Peixoto RD, Ferreira AR, Cleary JM, Fogacci JP, Vasconcelos JP, Jácome AA. Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy. J Gastrointest Cancer 2022. [PMID: 35288863 DOI: 10.1007/s12029-022-00816-0] [Reference Citation Analysis]
582 Auci DL, Egilmez NK. Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells. J Gastroenterol Pancreatol Liver Disord. 2016;3. [PMID: 28603774 DOI: 10.15226/2374-815x/3/4/00166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
583 Principi M, Losurdo G, Iannone A, Contaldo A, Deflorio V, Ranaldo N, Pisani A, Ierardi E, Di Leo A, Barone M. Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population. Ann Gastroenterol. 2018;31:469-473. [PMID: 29991892 DOI: 10.20524/aog.2018.0273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
584 Payne SC, Shepherd RK, Sedo A, Fallon JB, Furness JB. An objective in vivo diagnostic method for inflammatory bowel disease. R Soc Open Sci 2018;5:180107. [PMID: 29657828 DOI: 10.1098/rsos.180107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
585 Rogala AR, Schoenborn AA, Fee BE, Cantillana VA, Joyce MJ, Gharaibeh RZ, Roy S, Fodor AA, Sartor RB, Taylor GA, Gulati AS. Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice. Dis Model Mech 2018;11:dmm031070. [PMID: 29361512 DOI: 10.1242/dmm.031070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
586 Al-Dwairi A, Alqudah M, Al-Shboul O, Alfaqih M, Alomari D. Metformin exerts anti-inflammatory effects on mouse colon smooth muscle cells in vitro. Exp Ther Med 2018;16:985-92. [PMID: 30116349 DOI: 10.3892/etm.2018.6222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
587 Yang S, Li F, Lu S, Ren L, Bian S, Liu M, Zhao D, Wang S, Wang J. Ginseng root extract attenuates inflammation by inhibiting the MAPK/NF-κB signaling pathway and activating autophagy and p62-Nrf2-Keap1 signaling in vitro and in vivo. J Ethnopharmacol 2022;283:114739. [PMID: 34648903 DOI: 10.1016/j.jep.2021.114739] [Reference Citation Analysis]
588 Akhuemonkhan E, Parian A, Miller K, Hanauer S, Hutfless S. Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014. BMJ Open Gastroenterol. 2017;4:e000155. [PMID: 28944071 DOI: 10.1136/bmjgast-2017-000155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
589 Soroosh A, Fang K, Hoffman JM, Law IKM, Videlock E, Lokhandwala ZA, Zhao JJ, Hamidi S, Padua DM, Frey MR, Pothoulakis C, Rankin CR. Loss of miR-24-3p promotes epithelial cell apoptosis and impairs the recovery from intestinal inflammation. Cell Death Dis 2022;13. [DOI: 10.1038/s41419-021-04463-4] [Reference Citation Analysis]
590 Shi T, Xie Y, Fu Y, Zhou Q, Ma Z, Ma J, Huang Z, Zhang J, Chen J. The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Mucosal Immunol 2017;10:983-95. [PMID: 27901018 DOI: 10.1038/mi.2016.102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
591 Chen L, Jing T, Lin Z, Song W, Du W, Fan X, Li C, Li S, Xie F, Ou X, Huang L, Ma J. Metabolomic and transcriptomic responses of mouse testis to the dextran sulfate sodium induced colitis. Reproductive Toxicology 2022;108:35-42. [DOI: 10.1016/j.reprotox.2022.01.005] [Reference Citation Analysis]
592 Kang J, Kugathasan S, Georges M, Zhao H, Cho JH; NIDDK IBD Genetics Consortium. Improved risk prediction for Crohn’s disease with a multi-locus approach. Hum Mol Genet. 2011;20:2435-2442. [PMID: 21427131 DOI: 10.1093/hmg/ddr116] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
593 Jun JC, Cominelli F, Abbott DW. RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol 2013;94:927-32. [PMID: 23794710 DOI: 10.1189/jlb.0213109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
594 Kempski J, Brockmann L, Gagliani N, Huber S. TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis. Front Immunol 2017;8:1373. [PMID: 29118756 DOI: 10.3389/fimmu.2017.01373] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
595 Andreou NP, Legaki E, Gazouli M. Inflammatory bowel disease pathobiology: the role of the interferon signature. Ann Gastroenterol 2020;33:125-33. [PMID: 32127733 DOI: 10.20524/aog.2020.0457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
596 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
597 Lu C, Amin MA, Fox DA. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders. J Immunol 2020;204:3-11. [PMID: 31848300 DOI: 10.4049/jimmunol.1900868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
598 Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, Zhang T, Rohlf FJ, Zhu W, Gu C. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One. 2012;7:e26284. [PMID: 22719818 DOI: 10.1371/journal.pone.0026284] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 15.9] [Reference Citation Analysis]
599 Negroni A, Colantoni E, Vitali R, Palone F, Pierdomenico M, Costanzo M, Cesi V, Cucchiara S, Stronati L. NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells. Inflamm Res. 2016;65:803-813. [PMID: 27335178 DOI: 10.1007/s00011-016-0964-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
600 Branco JC, Cardoso MF, Anapaz V, Lourenço LC, Oliveira AM, Rodrigues CG, Santos L, Reis JA. Vitamin D Deficiency in a Portuguese Cohort of Patients with Inflammatory Bowel Disease: Prevalence and Relation to Disease Activity. GE Port J Gastroenterol 2019;26:155-62. [PMID: 31192283 DOI: 10.1159/000488744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
601 Mosli M, Alzahrani A, Showlag S, Alshehri A, Hejazi A, Alnefaie M, Almaymuni A, Abdullahi M, Albeshir M, Alsulais E, Jawa H, Aljahdli E, Bazarah S, Qari Y. A cross-sectional survey of multi-generation inflammatory bowel disease consanguinity and its relationship with disease onset. Saudi J Gastroenterol 2017;23:337-40. [PMID: 29205186 DOI: 10.4103/sjg.SJG_125_17] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
602 Varol C, Zigmond E, Jung S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat Rev Immunol. 2010;10:415-426. [PMID: 20498668 DOI: 10.1038/nri2778] [Cited by in Crossref: 144] [Cited by in F6Publishing: 140] [Article Influence: 12.0] [Reference Citation Analysis]
603 Kang YH, Biswas A, Field M, Snapper SB. STAT1 signaling shields T cells from NK cell-mediated cytotoxicity. Nat Commun 2019;10:912. [PMID: 30796216 DOI: 10.1038/s41467-019-08743-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
604 Fan H, Xu M, Tang Q. Aryl hydrocarbon receptor and its ligands for regulation of Th17/Treg cell differentiation in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(19): 3101-3108 [DOI: 10.11569/wcjd.v23.i19.3101] [Reference Citation Analysis]
605 Park S, Chun J, Han KD, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Dose-response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol. 2019;54:881-890. [PMID: 31093771 DOI: 10.1007/s00535-019-01589-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
606 Limdi JK. Dietary practices and inflammatory bowel disease. Indian J Gastroenterol 2018;37:284-92. [PMID: 30209778 DOI: 10.1007/s12664-018-0890-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
607 Mizoguchi E, Low D, Ezaki Y, Okada T. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. Intest Res. 2020;18:151-167. [PMID: 32326669 DOI: 10.5217/ir.2019.09154] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
608 Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology. 2011;141:653-662, 662.e1-4. [PMID: 21679711 DOI: 10.1053/j.gastro.2011.04.053] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
609 Katsurada T, Kobayashi W, Tomaru U, Baba T, Furukawa S, Ishizu A, Takeda K, Sakamoto N, Asaka M, Takeda H, Kasahara M. Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis. PLoS One 2012;7:e44113. [PMID: 22970169 DOI: 10.1371/journal.pone.0044113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
610 Ko JZ, Johnson S, Dave M. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.Biomolecules. 2021;11. [PMID: 33440772 DOI: 10.3390/biom11010082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
611 Song JL, Choi JH, Seo JH, Lim YI, Park KY. Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice. J Med Food 2014;17:1027-35. [PMID: 25188463 DOI: 10.1089/jmf.2013.3119] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
612 Lee SJ, Noh KT, Kang TH, Han HD, Shin SJ, Soh BY, Park JH, Shin YK, Kim HW, Yun CH, Park WS, Jung ID, Park YM. The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4. BMB Rep 2014;47:115-20. [PMID: 24393523 DOI: 10.5483/bmbrep.2014.47.2.277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
613 Marafini I, Stolfi C, Troncone E, Lolli E, Onali S, Paoluzi OA, Fantini MC, Biancone L, Calabrese E, Di Grazia A, Monteleone I, Lenti MV, Di Sabatino A, Monteleone G. A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn's Disease: A Phase II, Open-Label Study. BioDrugs 2021;35:325-36. [PMID: 33871807 DOI: 10.1007/s40259-021-00482-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
614 Sładek M, Wasilewska A, Swiat A, Cmiel A. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy. Prz Gastroenterol 2014;9:232-41. [PMID: 25276255 DOI: 10.5114/pg.2014.45106] [Reference Citation Analysis]
615 Mangerich A, Dedon PC, Fox JG, Tannenbaum SR, Wogan GN. Chemistry meets biology in colitis-associated carcinogenesis. Free Radic Res. 2013;47:958-986. [PMID: 23926919 DOI: 10.3109/10715762.2013.832239] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
616 Kuo CJ, Yu KH, See LC, Chiu CT, Su MY, Hsu CM, Kuo CF, Chiou MJ, Liu JR, Wang HW. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci. 2015;60:2454-2462. [PMID: 25837597 DOI: 10.1007/s10620-015-3630-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
617 Mazur-Bialy AI, Bilski J, Wojcik D, Brzozowski B, Surmiak M, Hubalewska-Mazgaj M, Chmura A, Magierowski M, Magierowska K, Mach T, Brzozowski T. Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers. Nutrients. 2017;9. [PMID: 28425943 DOI: 10.3390/nu9040410] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
618 Venkatapurapu SP, Iwakiri R, Udagawa E, Patidar N, Qi Z, Takayama R, Kumar K, Sato Y, Behar M, Offner P, Dwivedi G, Miyasaka H, Suzuki RK, Hamada AL, D'Alessandro PM, Fernandez J. A Computational Platform Integrating a Mechanistic Model of Crohn's Disease for Predicting Temporal Progression of Mucosal Damage and Healing. Adv Ther 2022. [PMID: 35581423 DOI: 10.1007/s12325-022-02144-y] [Reference Citation Analysis]
619 Dhillon SS, Mastropaolo LA, Murchie R, Griffiths C, Thöni C, Elkadri A, Xu W, Mack A, Walters T, Guo C, Mack D, Huynh H, Baksh S, Silverberg MS, Brumell JH, Snapper SB, Muise AM. Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol 2014;5:e46. [PMID: 24430113 DOI: 10.1038/ctg.2013.17] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
620 Kim SW, Kim S, Son M, Cheon JH, Park YS. Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling. Sci Rep 2020;10:2232. [PMID: 32042047 DOI: 10.1038/s41598-020-59314-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
621 Cheah JX, Assarzadegan N, Ghosh J, Connolly CM, Gelber AC. Intolerable unilateral hip pain: Clues from the history. The American Journal of Medicine 2022. [DOI: 10.1016/j.amjmed.2022.04.020] [Reference Citation Analysis]
622 Lapp RT, Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol. 2011;13:573-576. [PMID: 20574849 DOI: 10.1007/s11307-010-0367-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
623 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
624 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
625 Cistaro A, Quartuccio N, Mansi L, Signore A, Dolci M, Treglia G. The Role of Positron Emission Tomography in Inflammatory Bowel Disease. Eur J Inflamm 2012;10:251-6. [DOI: 10.1177/1721727x1201000301] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
626 Perez-Burgos A, Wang L, McVey Neufeld KA, Mao YK, Ahmadzai M, Janssen LJ, Stanisz AM, Bienenstock J, Kunze WA. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol. 2015;593:3943-3957. [PMID: 26084409 DOI: 10.1113/jp270229] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
627 Lee JT, Frank DN, Ramakrishnan V. Microbiome of the paranasal sinuses: Update and literature review. Am J Rhinol Allergy 2016;30:3-16. [PMID: 26867525 DOI: 10.2500/ajra.2016.30.4255] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
628 Rosh JR, Hyams JS. Pediatric UC drug development: a GREAT idea now needs a GRAND conversation. J Pediatr Gastroenterol Nutr 2014;58:677-8. [PMID: 24625967 DOI: 10.1097/MPG.0000000000000367] [Reference Citation Analysis]
629 Block M, Mölne J, Leffler H, Börjesson L, Breimer ME. Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis. Biomed Res Int 2016;2016:5989128. [PMID: 26885508 DOI: 10.1155/2016/5989128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
630 Hu J, Peter I. Evidence of expression variation and allelic imbalance in Crohn's disease susceptibility genes NOD2 and ATG16L1 in human dendritic cells. Gene 2013;527:496-502. [PMID: 23850724 DOI: 10.1016/j.gene.2013.06.066] [Reference Citation Analysis]
631 Li Y, Chen HL, Bannick N, Henry M, Holm AN, Metwali A, Urban JF Jr, Rothman PB, Weiner GJ, Blazar BR, Elliott DE, Ince MN. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. J Immunol 2015;194:1011-20. [PMID: 25527786 DOI: 10.4049/jimmunol.1303099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
632 Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495-507. [PMID: 25808229 DOI: 10.1007/s00535-015-1064-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 17.7] [Reference Citation Analysis]
633 Calafat M, Mañosa M, Ricart E, Nos P, Iglesias-Flores E, Vera I, López-SanRomán A, Guardiola J, Taxonera C, Mínguez M, Martín-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, García-López S, Márquez L, Gomollón F, Barrio J, Esteve M, Muñoz F, Gisbert JP, Gutiérrez A, Hinojosa J, Argüelles-Arias F, Busquets D, Bujanda L, Pérez-Calle JL, Sicilia B, Merino O, Martínez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodríguez C, García-Sepulcre MF, Monfort D, Cañete F, Domènech E; ENEIDA Study Group of GETECCU. Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry. J Crohns Colitis 2021:jjab213. [PMID: 34864947 DOI: 10.1093/ecco-jcc/jjab213] [Reference Citation Analysis]
634 El-Nakeep S, Shawky A, Abbas SF, Abdel Latif O. Stem cell transplantation for induction of remission in medically refractory Crohn's disease. Cochrane Database Syst Rev 2022;5:CD013070. [PMID: 35556242 DOI: 10.1002/14651858.CD013070.pub2] [Reference Citation Analysis]
635 van der Marel S, Majowicz A, Kwikkers K, van Logtenstein R, te Velde AA, De Groot AS, Meijer SL, van Deventer SJ, Petry H, Hommes DW, Ferreira V. Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. World J Gastroenterol 2012; 18(32): 4288-4299 [PMID: 22969191 DOI: 10.3748/wjg.v18.i32.4288] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
636 Bourgonje AR, Gabriëls RY, de Borst MH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G. Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease. Antioxidants (Basel) 2019;8:E351. [PMID: 31480545 DOI: 10.3390/antiox8090351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
637 Facchini FA, Di Fusco D, Barresi S, Luraghi A, Minotti A, Granucci F, Monteleone G, Peri F, Monteleone I. Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis. Eur J Clin Pharmacol 2020;76:409-18. [PMID: 31982922 DOI: 10.1007/s00228-019-02799-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
638 Meng X, Dunsmore G, Koleva P, Elloumi Y, Wu RY, Sutton RT, Ambrosio L, Hotte N, Nguyen V, Madsen KL, Dieleman LA, Chen H, Huang V, Elahi S. The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn. J Crohns Colitis 2019;13:431-41. [PMID: 30418545 DOI: 10.1093/ecco-jcc/jjy186] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
639 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
640 Lahiri A, Hedl M, Yan J, Abraham C. Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes. Nat Commun 2017;8:15614. [PMID: 28593945 DOI: 10.1038/ncomms15614] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
641 Ramanan D, Tang MS, Bowcutt R, Loke P, Cadwell K. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 2014;41:311-24. [PMID: 25088769 DOI: 10.1016/j.immuni.2014.06.015] [Cited by in Crossref: 148] [Cited by in F6Publishing: 142] [Article Influence: 18.5] [Reference Citation Analysis]
642 Nishida A, Lau CW, Zhang M, Andoh A, Shi HN, Mizoguchi E, Mizoguchi A. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012;142:865-874.e2. [PMID: 22202458 DOI: 10.1053/j.gastro.2011.12.036] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
643 Levy-Shraga Y, Megnazi O, Modan-Moses D, Tripto-Shkolnik L, Gruber N, Haberman Y, Shouval DS, Weiss B. Trabecular Bone Score in Children and Adolescents With Inflammatory Bowel Diseases. J Clin Densitom 2021;24:243-51. [PMID: 33189561 DOI: 10.1016/j.jocd.2020.10.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
644 Chinnadurai R, Ng S, Velu V, Galipeau J. Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease. World J Gastroenterol 2015; 21(16): 4779-4787 [PMID: 25944991 DOI: 10.3748/wjg.v21.i16.4779] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
645 Kobayashi M, Lei NY, Wang Q, Wu BM, Dunn JC. Orthogonally oriented scaffolds with aligned fibers for engineering intestinal smooth muscle. Biomaterials 2015;61:75-84. [PMID: 26001072 DOI: 10.1016/j.biomaterials.2015.05.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
646 Barreau F, Tisseyre C, Ménard S, Ferrand A, Carriere M. Titanium dioxide particles from the diet: involvement in the genesis of inflammatory bowel diseases and colorectal cancer. Part Fibre Toxicol 2021;18:26. [PMID: 34330311 DOI: 10.1186/s12989-021-00421-2] [Reference Citation Analysis]
647 Michael S, Abdel-Aziz H, Weiser D, Müller CE, Kelber O, Nieber K. Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations. Naunyn Schmiedebergs Arch Pharmacol 2012;385:411-21. [PMID: 22160002 DOI: 10.1007/s00210-011-0714-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
648 Kurmaeva E, Lord JD, Zhang S, Bao JR, Kevil CG, Grisham MB, Ostanin DV. T cell-associated α4β7 but not α4β1 integrin is required for the induction and perpetuation of chronic colitis. Mucosal Immunol. 2014;7:1354-1365. [PMID: 24717354 DOI: 10.1038/mi.2014.22] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
649 Pérez-Jeldres T, Tyler CJ, Boyer JD, Karuppuchamy T, Yarur A, Giles DA, Yeasmin S, Lundborg L, Sandborn WJ, Patel DR, Rivera-Nieves J. Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists. Front Pharmacol 2019;10:212. [PMID: 30930775 DOI: 10.3389/fphar.2019.00212] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
650 Asano K, Esaki M, Umeno J, Hirano A, Maehata Y, Moriyama T, Nakamura S, Matsumoto T, Kitazono T. Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis. J Gastroenterol 2015;50:1094-102. [PMID: 25787843 DOI: 10.1007/s00535-015-1062-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
651 Yoneno K, Hisamatsu T, Shimamura K, Kamada N, Ichikawa R, Kitazume MT, Mori M, Uo M, Namikawa Y, Matsuoka K, Sato T, Koganei K, Sugita A, Kanai T, Hibi T. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. Immunology. 2013;139:19-29. [PMID: 23566200 DOI: 10.1111/imm.12045] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 10.4] [Reference Citation Analysis]
652 Lawrance IC. What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails? World J Gastroenterol 2014; 20(5): 1248-1258 [PMID: 24574799 DOI: 10.3748/wjg.v20.i5.1248] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
653 Zhou Y, Liu H, Song J, Cao L, Tang L, Qi C. Sinomenine alleviates dextran sulfate sodium‑induced colitis via the Nrf2/NQO‑1 signaling pathway. Mol Med Rep 2018;18:3691-8. [PMID: 30106158 DOI: 10.3892/mmr.2018.9378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
654 Shang J, Wang X, Wang W, Pan H, Liu S, Li L, Chen L, Xia B. Association between Toll-Like Receptor 9-1237T/C Polymorphism and the Susceptibility of Inflammatory Bowel Diseases: A Meta-Analysis. Yonsei Med J 2016;57:153-64. [PMID: 26632396 DOI: 10.3349/ymj.2016.57.1.153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
655 Gao JG, Yu MS, Zhang MM, Gu XW, Ren Y, Zhou XX, Chen D, Yan TL, Li YM, Jin X. Adipose-derived mesenchymal stem cells alleviate TNBS-induced colitis in rats by influencing intestinal epithelial cell regeneration, Wnt signaling, and T cell immunity. World J Gastroenterol 2020; 26(26): 3750-3766 [PMID: 32774055 DOI: 10.3748/wjg.v26.i26.3750] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
656 Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019;8:E628. [PMID: 31234447 DOI: 10.3390/cells8060628] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
657 Kathania M, Tsakem EL, Theiss AL, Venuprasad K. Gut Microbiota Contributes to Spontaneous Colitis in E3 Ligase Itch-Deficient Mice. J Immunol 2020;204:2277-84. [PMID: 32169841 DOI: 10.4049/jimmunol.1701478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
658 Huang Y, Zaas AK, Rao A, Dobigeon N, Woolf PJ, Veldman T, Øien NC, McClain MT, Varkey JB, Nicholson B, Carin L, Kingsmore S, Woods CW, Ginsburg GS, Hero AO 3rd. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet 2011;7:e1002234. [PMID: 21901105 DOI: 10.1371/journal.pgen.1002234] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 12.4] [Reference Citation Analysis]
659 Ananthakrishnan AN, Khalili H, Pan A, Higuchi LM, de Silva P, Richter JM, Fuchs CS, Chan AT. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol. 2013;11:57-62. [PMID: 22944733 DOI: 10.1016/j.cgh.2012.08.032] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
660 Gierut JJ, Wood LB, Lau KS, Lin YJ, Genetti C, Samatar AA, Lauffenburger DA, Haigis KM. Network-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epithelium. Sci Signal 2015;8:ra129. [PMID: 26671150 DOI: 10.1126/scisignal.aac7235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
661 Scherl EJ, Kumar S, Warren RU. Review of the safety and efficacy of ustekinumab. Therap Adv Gastroenterol 2010;3:321-8. [PMID: 21180612 DOI: 10.1177/1756283X10374216] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
662 Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One. 2013;8:e56944. [PMID: 23457642 DOI: 10.1371/journal.pone.0056944] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 12.2] [Reference Citation Analysis]
663 Nguyen AV, Wu YY, Lin EY. STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer. World J Gastroenterol 2014; 20(30): 10279-10287 [PMID: 25132744 DOI: 10.3748/wjg.v20.i30.10279] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
664 Chan SS, Luben R, van Schaik F, Oldenburg B, Bueno-de-Mesquita HB, Hallmans G, Karling P, Lindgren S, Grip O, Key T. Carbohydrate intake in the etiology of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20:2013-2021. [PMID: 25265262 DOI: 10.1097/mib.0000000000000168] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 7.1] [Reference Citation Analysis]
665 Strauch U, Schölmerich J. Emerging drugs to treat Crohn's disease. Expert Opin Emerg Drugs 2010;15:309-22. [PMID: 20402560 DOI: 10.1517/14728214.2010.480972] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
666 Yang L, Yan Y. Protein kinases are potential targets to treat inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2014; 5(4): 209-217 [PMID: 25374761 DOI: 10.4292/wjgpt.v5.i4.209] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
667 Yi J, Bergstrom K, Fu J, Shan X, McDaniel JM, McGee S, Qu D, Houchen CW, Liu X, Xia L. Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitis. Cell Death Differ 2019;26:1656-69. [PMID: 30478383 DOI: 10.1038/s41418-018-0237-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
668 Pan WJ, Köck K, Rees WA, Sullivan BA, Evangelista CM, Yen M, Andrews JM, Radford-Smith GL, Prince PJ, Reynhardt KO. Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases. Br J Clin Pharmacol. 2014;78:1315-1333. [PMID: 24803302 DOI: 10.1111/bcp.12418] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
669 Liu TJ, Shi YY, Wang EB, Zhu T, Zhao Q. AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease. Mol Med Rep 2016;13:1156-62. [PMID: 26676112 DOI: 10.3892/mmr.2015.4686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
670 Barrett CW, Short SP, Williams CS. Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut. Cell Mol Life Sci 2017;74:607-16. [PMID: 27563706 DOI: 10.1007/s00018-016-2339-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
671 Liu Y, Zhu F, Li H, Fan H, Wu H, Dong Y, Chu S, Tan C, Wang Q, He H, Gao F, Leng X, Zhou Q, Zhu X. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis. Aging (Albany NY) 2020;12:14966-77. [PMID: 32713852 DOI: 10.18632/aging.103555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
672 M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33-47. [PMID: 24833941 DOI: 10.4137/cgast.s12731] [Cited by in Crossref: 120] [Cited by in F6Publishing: 82] [Article Influence: 13.3] [Reference Citation Analysis]
673 Oshima S, Watanabe M. Genetic and environmental factors drive personalized medicine for Crohn's disease. J Clin Invest 2018;128:4758-60. [PMID: 30320603 DOI: 10.1172/JCI124303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
674 Robinson AM, Rahman AA, Miller S, Stavely R, Sakkal S, Nurgali K. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res Ther 2017;8:87. [PMID: 28420434 DOI: 10.1186/s13287-017-0540-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
675 Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A. Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease. World J Gastroenterol 2016; 22(44): 9734-9743 [PMID: 27956797 DOI: 10.3748/wjg.v22.i44.9734] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
676 Czubkowski P, Osiecki M, Szymańska E, Kierkuś J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med 2020;20:481-91. [PMID: 32785793 DOI: 10.1007/s10238-020-00639-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
677 Di Fusco D, Dinallo V, Marafini I, Figliuzzi MM, Romano B, Monteleone G. Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease. Front Pharmacol 2019;10:305. [PMID: 30983999 DOI: 10.3389/fphar.2019.00305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
678 Garg A, Hundal J, Strunk A. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States. JAMA Dermatol. 2018;154:814-818. [PMID: 29800049 DOI: 10.1001/jamadermatol.2018.0878] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
679 Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 51-65 [PMID: 26855812 DOI: 10.4292/wjgpt.v7.i1.51] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
680 Song JY, Kang HJ, Hong JS, Kim CJ, Shim JY, Lee CW, Choi J. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 2017;7:9412. [PMID: 28842625 DOI: 10.1038/s41598-017-09827-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
681 Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. ScientificWorldJournal 2011;11:2491-505. [PMID: 22235180 DOI: 10.1100/2011/517152] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
682 Kim TK, Kang SH, Moon HS, Sung JK, Jeong HY, Eun HS. Pulmonary Sarcoidosis That Developed During the Treatment of a Patient With Crohn Disease by Using Infliximab. Ann Coloproctol 2017;33:74-7. [PMID: 28503520 DOI: 10.3393/ac.2017.33.2.74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
683 Tontini GE, Rath T, Neumann H. Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases. World J Gastroenterol 2016; 22(3): 1246-1259 [PMID: 26811662 DOI: 10.3748/wjg.v22.i3.1246] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
684 Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J, Hu H, Wang R, Zhang J. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Adv Sci (Weinh) 2019;6:1900610. [PMID: 31559126 DOI: 10.1002/advs.201900610] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
685 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Reference Citation Analysis]
686 Dougan M, Pietropaolo M. Time to dissect the autoimmune etiology of cancer antibody immunotherapy. J Clin Invest 2020;130:51-61. [PMID: 31895048 DOI: 10.1172/JCI131194] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
687 Yuan K, Li X, Lu Q, Zhu Q, Jiang H, Wang T, Huang G, Xu A. Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review. Front Pharmacol 2019;10:1469. [PMID: 31866868 DOI: 10.3389/fphar.2019.01469] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
688 Janssen KMJ, Hop H, Vissink A, Dijkstra G, de Smit MJ, Brouwer E, Westra J. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease. Int J Environ Res Public Health 2020;17:E8054. [PMID: 33139618 DOI: 10.3390/ijerph17218054] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Jakobsson T, Vedin LL, Hassan T, Venteclef N, Greco D, D'Amato M, Treuter E, Gustafsson JÅ, Steffensen KR. The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol 2014;7:1416-28. [PMID: 24803164 DOI: 10.1038/mi.2014.31] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
690 Stappenbeck TS, McGovern DPB. Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease. Gastroenterology 2017;152:322-6. [PMID: 27729212 DOI: 10.1053/j.gastro.2016.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
691 Zhang T, DeSimone RA, Jiao X, Rohlf FJ, Zhu W, Gong QQ, Hunt SR, Dassopoulos T, Newberry RD, Sodergren E, Weinstock G, Robertson CE, Frank DN, Li E. Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human ileum-associated microbial composition. PLoS One. 2012;7:e30044. [PMID: 22719822 DOI: